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CHAPTER 1 
General Introduction 
Introduction 
Leishmania spp. are protozoan parasites known to infect humans and animals. They 
are obligate intracellular parasites that primarily infect macrophages in the mammalian host 
but are less host cell specific in the vector host, the sandfly. Leishmaniasis is spread in 
different parts of the world (about 88 countries), where millions of people either are infected 
or at risk of being infected. It is considered the third most important parasitic disease after 
malaria and trypanosomiasis. Clinical outcome of leishmaniasis is dependent on the strain of 
Leishmania and immunological status of the host. Recently, research interest to study 
Leishmania as a disease increased with higher incidence of this disease in immuno­
competent people. In the US, there has been more attention to this disease due to roughly 800 
cases of leishmaniasis reported in soldiers serving in endemic areas of Iraq and Afghanistan. 
Studying Leishmania is beneficial not only in regard to disease prevention and 
treatment, but also for its role in promoting a basic understanding of the immune system. 
This has particularly been shown in models of Leishmania infection in inbred strains of mice 
where different strains of mice have different response to infection with the same species of 
Leishmania or where different species of Leishmania respond differently to infection in the 
same strain of mice. In this thesis we utilize a variation of responses in C3H mice to different 
Leishmania species. 
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C3H mice infected with Leishmania major heal 10-12 weeks post-infection while 
Leishmania amazonensis develop a persistent chronic lesion. This difference in infection 
outcome correlates with differences in the immune response induced in vivo to each 
Leishmania spp. The main cell types of the immune system known to be involved in 
responding to Leishmania infection are CD4+ T cells, dendritic cells (DCs), and 
macrophages. Cell mediated immunity characterized by induction of Thl polarized CD4+ T 
cells sensitized by proper activation from DCs, leads to productive macrophage activation 
including the release of cytotoxic factors necessary to kill the intracellular parasite. 
The work presented in this thesis summarizes our studies aimed at understanding the 
resistance of L. amazonensis amastigotes to macrophage killing in vitro in comparison to L. 
major amastigotes infection. These studies showed not only a resistance of L. amazonensis to 
macrophage killing despite identical macrophage activation methods that induce killing in L. 
major, but also that cytotoxic factors required to induce L. amazonensis killing are different 
from those that regularly kill L. major and are more potent. 
The objective of the first study was to analyze the reasons for differential killing of L. 
amazonensis and L. major in bone marrow derived macrophages (BMM) in vitro using LPS 
and IFNy as an identical activation method. For this study a working hypothesis was 
developed: L. amazonensis is more resistant to macrophage activation in vitro as compared to 
L. major infection under the same activation methods. As the differential resistance of L. 
amazonensis to immune response in C3H mice in vivo compared to L. major was 
demonstrated, the actual mechanism for this resistance in macrophages is not clear. At the 
same time, Leishmania spp. were shown to evade macrophages activation by different 
mechanisms. 
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The objective of the second study was to test the ability of draining lymph node 
(DLN) cells from healed L. major to activate BMM to control L. amazonensis infection in 
vitro and to characterize the cell types involved and the mechanism of activation. We 
hypothesized that DLN cells from L. major infected mice induce activation of BMM infected 
with L. amazonensis to control the infection. A previous study from our laboratory 
determined that healed L. major infected C3H mice could heal a secondary L. amazonensis 
infection in vivo. There are no previous reports for LN cells from infected mice to activate 
macrophages in vitro. 
The objective of the third study was to characterize the role of antibodies and Fey 
receptors in macrophage activation to induce killing of intracellular L. amazonensis. Our 
hypothesis for this study is that Leishmania infection of macrophages would manipulate 
expression of Fey receptors therefore causing regulation of macrophages activation. A 
previous role for Fc receptor was shown in antibody opsonized Leishmania macrophage 
invasion and evasion of the immune system, while in the previous chapter of this thesis we 
showed an antibody dependent activation of macrophages secreted from DLN of L. major 
infected mice. The actual role of Leishmania infection on macrophages expression of Fey 
receptor was yet unknown. 
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Literature review 
1. Leishmania 
1.1 History and Epidemiology 
Cutaneous lesions caused by Leishmania were first described in people of the Old 
World at least two thousand years ago (189), while illustration of lesions have been found on 
human faces of decorating pottery created 1500 years ago in Peru and Ecuador (130). 
Leishmania lesions were first described as part of modern medicine by Russell in 1756. 
Subsequently, Leishman reported the identification of the parasite in India in 1900 (14). 
Leishmaniasis is known by other names including; sore, Aleppo evil, Delhi boil, Baghdad 
sore, Rose of Jericho, Chiclero's ulcer, uta, espundia (mucosal form), forest yaws, Dumdum 
fever (visceral form), kala-azar, and black fever (42). 
88 countries are endemic for leishmaniasis of which 72 countries are developing 
countries. About 90% of the visceral leishmaniasis occurs in five countries: Sudan, India, 
Bangladesh, Nepal, and Brazil. While in only eight countries 90% of cutaneous leishmaniasis 
occur: Afghanistan, Algeria, Brazil, Iran, Peru, Saudi Arabia and Syria (256, 9). 
The estimated global prevalence of leishmaniasis is 12 million people with an 
incidence of 1.5-2 million cases yearly (about 1-1.5 million cutaneous cases and 500 
thousand visceral leishmaniasis cases) (256). Increasing risk factors like urbanization play a 
major role in higher incidence rates, as prior to 1950 only one third of the worlds population 
live in cities, whereas today more than 50% of people are city dwellers. This has brought 
traditionally rural diseases into urban areas (168). Climatic changes can also modify 
geographical distribution of vector, as the distribution of Leishmania is mainly determined by 
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the distribution of sandfly vectors (Phlebotomus sp and Lutzomyia sp), which is specifically 
defined by particular environmental breeding habitats. 
Recently, emergence of HIV/Leishmania co-infection reported in 34 countries 
globally, has vastly increased the risk of Leishmania-infected people for developing visceral 
illness, particularly in Southern Europe (8,205) 
1.2 Strains (New World and Old World) 
Leishmania species are generally considered to be indistinguishable morphologically. 
Extrinsic characters, such as clinical features of disease, geographical distribution, and 
behavior in laboratory animals or vectors and intrinsic ones; immunological, biochemical, or 
molecular criteria are used for identification (56) (Table 1). Leishmania has four clinical 
forms: cutaneous (CL), mucocutaneous (MCL), diffuse cutaneous (DCL), and visceral (VL). 
The clinical expression of leishmaniasis depends not only on the genotypic potential of the 
different parasites, but also on the immunological status of the patient as the cutaneous form 
can transform to the visceral form in immuno-competent patients (6, 144). 
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Table 1 Taxonomy and classification of Leishmania (adapted from (154) 
New World Old World 
Kingdom Protista 
Subkingdom Protozoa 
Phylum Sarcomastigophora 
Subphylum Mastigophora 
Class Zoomastigophora 
Order Kinetplastida 
Family T ry panosomatidae 
Section Salivaria 
Genus Leishmania 
Species 
Disease 
form* 
L. mexicana 
L. venezuelensis 
L. peruviana 
L. lansoni 
L. panamensis 
L. braziliensis 
L. amazonensis 
L. pifanoi 
L. chagasi 
L. major CL 
L. tropica CL 
CL 
CL 
CL 
CL, MCL 
L. aethiopica CL, DCL 
CL, DCL 
L. infantum 
L. donovani 
VL, CL 
VL 
*CL: Cutaneous, MCL: Mucocutaneous, DCL: Diffuse cutaneous, VL: Visceral. 
1.3 Life cycle and transmission 
Leishmania parasites exist in two morphological forms, amastigotes and 
promastigotes, which are found in the mammalian host and sandfly, respectively. 
Amastigotes entering into the sandfly midgut after a bloodmeal initially transform into 
procyclic promastigotes. Procyclic promastigotes are non-infective and rapidly divide in the 
sandfly midgut. They then transform into infective metacyclic promastigotes within 4-7 days, 
which migrate to the pharynx of the sandfly. There are 6 developmental forms of 
promastigotes distinguished morphologically: procyclic, nectomenad, leptomonad, 
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haptomonad, paramastigote, and metacyclic promastigotes (82, 203). Following the bite of 
an infected sandfly, Leishmania metacyclic promastigotes undergo phagocytosis by host 
macrophages or dendritic cells through binding to various receptors including the 
complement receptors and Fc receptors (discussed in section 2.1) (147). Once a promastigote 
is inside a phagosome, fusion with lysosomes and endosomes occurs forming a 
phagolysosome in which promastigotes transform to amastigotes. The multiplication of 
amastigotes within macrophages causes eventual rupture of the macrophage and allows 
spread of infection to other macrophages. The Leishmania life cycle is completed when a 
sandfly feeds on blood of an infected host taking up the amastigotes (90). 
The endemic transmission cycle of Leishmania typically occurs through the sandfly 
and mammalian reservoirs including rodents and canines however, humans can be incidental 
hosts. More recently, with HIV infection a new mode of transmission was recorded via 
needle between HIV infected people (161). 
1.4 Vector and sandfly saliva 
Sandflies, the vector for Leishmania infection, belong to the family of Psychodidae 
and subfamily Phlebotominae. There are about 700 species of sandflies of which 70 are 
known to be able to serve as vectors for leishmaniasis (125). 
Only the female sandflies transmit the disease as they are hematogenous (feed on 
blood), they breed and lay eggs in environments where the larvae can find appropriate 
organic matter, heat and humidity. Immature Phlebotmines are found in organically rich 
moist soils (Lutzomyai spp.) or contaminated soil of animal shelters (Phlebotmus spp.), as 
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well as in the burrows of certain rodents, in the bark of old trees, in ruined buildings and in 
cracks of house walls (reviewed in (71)). In searching for a blood meal, usually in the 
evening and at night, the female sandfly can cover a radius of a few to several hundred 
meters (107). 
Sandfly species are selective to which species of Leishmania can develop in their 
midgut. This specificity is dependent on cellular midgut receptors with specificity to a 
particular Leishmania species lipophosphoglycan (LPG). For example, L. amazonensis is 
transmitted by Lu. flaviscutellata, and L. major is transmitted by P. papatasi. based on their 
LPG structure (reviewed in (208)). 
When sandflies feed on the host blood they probe the skin creating a hemorrhagic 
pool. It has been shown that the parasite influences sandflyfeeding behavior by increasing 
probing. For example, 11 attempts of a single infected sand fly was recorded (reviewed in 
(107)). The main purpose of sandfly saliva is to induce vasodilation, prevent blood clotting, 
and promote immunosuppression. Saliva contains potent vasodilators including maxadilan 
(136) adenosine (202), and anti-platelet aggregation factors like apyrase (244) and 
prostaglandin E2 (201). Sandfly saliva components can also play a role in host 
immunosuppression. Several studies have shown that co-injection of salivary gland 
homogenates with Leishmania infection increase lesion size and exaggerates the infection 
outcome (16, 68, 141). Saliva has been shown to induce IL-4 production and inhibition of 
antigen presentation, IFN-y, iNOS and NO production (89, 123). Maxadilan, which is found 
in the saliva of Lu. longipalis (vector for L. chagasi), was found to inhibit T cell 
proliferation, and prevent delayed type hypersensitivity (DTH) response (195), as well as 
inhibit TNF-a expression by macrophages and increase IL-6, IL-10 and prostaglandin E2 
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production (220). Adenosine, which is found in both P. papatasi (vector for L. major) and 
Lu. longipalis saliva, induced enhancement of IL-10 production and suppression of IFN-y, 
TNF-a, IL-12 and NO production (94, 95, 134). The role for L. amazonensis vector (Lu. 
flaviscutellata) saliva is unknown yet, as the raising of this sandflies species in the laboratory 
is difficult. 
The role of sandflies saliva in Leishmania virulence can be seen when an infection 
can be established with few number of parasites transferred by the sandfly bite. On the other 
hand, new vaccines is being developed against components of the sandfly saliva based on the 
fact that people in areas endemic to Leishmania and exposed to multiple bites of sandflies are 
less likely to be infected with Leishmania. 
1.5 Surface determinants and virulence factors 
The expression of the surface components of Leishmania are species and stage 
specific. These components, in part, determine the virulence for the parasite in the vector and 
mammalian host (reviewed in (173)). 
1.5.1 Lipophosphoglycan (LPG) 
LPG is a major component of the promastigote surface but is found in low to non-
detectable levels in amastigotes (150). It is composed of 4 subunits: 1) oligosaccharide cap, 
2) polymer of repeating disaccharide-phosphate units, 3) glycan core and 4) 
phosphatidylinositol (GPI) anchor. Both the anchor and glycan core are conserved between 
Leishmania species while differences between species occur in the phosphorylated 
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oligosaccharide repeat branches and in the relative abundance of the cap structures (110). 
Structural differences in LPG are also seen in between stages of parasites, for example the 
length of LPG on L. major metacyclic promastigotes is almost twice that of procyclic 
promastigotes due to an additional side chain modification (152). These changes in LPG 
affect both the thickness and the type of attachment to the sandfly midgut (191). Conversely, 
there are no structural changes in L. mexicana LPG between stages of the promastigote (112), 
at the same time a lower level LPG in the promastigotes is seen when they reach the 
stationary phase (197). 
LPG was found to both play a role in resistance to complement and to scavenge 
oxygen radicals in vitro (226). LPG was also found to inhibit the rate of parasitophorous 
vacuole maturation (60). LPG-deficient L. major parasites were found to be less virulent both 
in vivo and in vitro (225,227). In contrast, LPG deficient L. mexicana were as virulent as 
wildtype, which indicates that LPG does not play a role as a virulence factor in L. mexicana 
(108). LPG can activate macrophages through Toll-like receptor-2 and promote synthesis of 
IFN-y and TNF-a (55) and to stimulate iNOS expression (193). Studies have suggested the 
down regulation of LPG expression in the amastigotes may play a role in evading 
macrophage activation. Finally, minimal role for LPG as virulence factor in L. mexicana 
complex compared to L. major parasites was reported. 
1.5.2 Proteophosphoglycans (PPG) 
PPG is a large family of extensively glycosylated proteins (162). There are three 
forms of PPG found in Leishmania; secreted filamentous PPG (fPPG) and a putative GPI-
anchored cell-associated form (mPPG) both in promastigotes, while amastigotes have one 
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secreted form (aPPG) (111). fPPG is a highly viscous mesh within which the parasite is 
embedded. It is believed that the gel-like matrix formed by fPPG trap the promastigotes 
inside the sandflies anterior gut. L. mexicana amastigotes secret more aPPG than L. major, 
this secretion inside parasitophorous vacuole cause the increase of vacuole size (188), and for 
that reason L. mexicana complex have large vacuoles. 
PPG-null mutant L. major parasites are less virulent and are more sensitive to 
complement lysis. Mice infected with PPG null mutant parasites do not develop lesions. PPG 
plays a role in scavenging oxygen radicals (227). In contrast, the PPG mutant L. mexicana is 
as virulent as wildtype parasites in both in vitro macrophage assays and in murine infection 
models (109). 
1.5.3 Leishmanolysin (Gp63) 
Gp63 is a zinc metalloproteinase that is highly expressed on promastigotes, 
particularly stationary phase parasites. This stage-specific expression of different isotypes is 
regulated by changes in mRNA stability and turnover (reviewed by (259)). 
Gp63 has been shown to hydrolyze complement components which attach to the 
parasite surface for opsonization by C3 degradation and converting C3b to inactive C3bi 
(22). Also, gp63 acts as a complement ligand for the parasite to enter the macrophages via 
complement receptor 3 (21). Gp63-deficient L. major develops normally in sandflies but they 
are more sensitive to complement. There is a delay in lesion formation in BALB/c mice after 
infection with these mutant parasites (121). 
Mutant L. amazonensis which have been genetically engineered to over-express gp63 
showed an enhanced capacity to migrate through extracellular matrix in vitro by degrading 
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collagen IV and fibronectin (153). In contrast, L. amazonensis gp63 null mutants have lower 
macrophage binding capacity and decreased intracellular growth (41). It seems that gp63 
plays a role in the intracellular survivability of L. amazonensis but not L. major. 
1.5.4 Glycosylinositolphospholipids (GIPL) 
GIPL are free glycosylphospholipids present in all stages of Leishmania. They are 
produced by all trypanosomatids suggesting their function as housekeeping molecules 
proposed to be important in maintaining plasma membrane (151). GIPL have been shown to 
be important for parasite invasion in macrophages by binding with serum mannose-binding 
protein or macrophage mannose-fucose receptor (235). Purified GIPL was found to modulate 
signal transduction pathway in macrophages by inhibiting PKC and NFKB/c-rel (235), which 
results in inhibiting IL-12 production (190) and iNOS production (193, 234). 
Mutation of L. amazonensis GIPL did not affect growth of extracellular promastigote 
stage of the parasite; instead reduced inactivity towards macrophages and decreased 
intracellular growth of axenic amastigotes were found (79). At the same time, mutant L. 
mexicana GIPL promastigotes grew normally in culture, but they were also less virulent than 
wildtype parasites in macrophages and susceptible mice (113). In contrast, the virulence of 
both amastigotes and promastigotes of L. major GIPL mutants was not affected (262). 
1.5.5 Cysteine peptidases (CP) 
Cysteine peptidases, also called cysteine protease, are group of enzymes produced in 
both stages of Leishmania and stored in the megasome,a large lysosome, of amastigotes or 
the multi-vesicular tubule-lysosome in promastigotes. The majority of studies preformed on 
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CP function were done on three forms of the enzymes; CPA, CPB, and CPC, all of which 
were identified as virulent factors fori, mexicana (reviewed in (169)). L. amazonensis andL. 
mexicana CPs were described to be responsible for MHCII degradation and inhibition of 
antigen presentation (54). Treatment with inhibitors of CPs induced a shift from a Th2 to a 
Thl response in BALB/c (49) and prevented the activation of TGF-(3 in a macrophage cell 
line in vitro (221). CPB deficient L. mexicana did not affect the parasite infectivity of 
macrophages in vitro, but reduced their infectivity in BALB/c mice in vivo (3, 58), C3H and 
C57BL/6 mice were able to heal infection with these parasites (26). Recently, L. mexicana 
was found to inhibit IL-12 production by macrophages via using CP to degrade IKCC, IK|3, and 
NFK|3, as well as inducing cleavage of JNK and ERK (29). CP inhibitors were found to 
reduce both L. major promastigote (in culture) and amastigotes intracellular growth (in 
macrophages) (217). These results show that CP have more significant role to L. major 
survival than L. amazonensis although CP function in L. amazonensis virulence. 
2. Macrophages 
Macrophages are part of the innate immune defense that recognizes foreign particle 
and non-self antigen by their surface receptors and subsequently engulf these particles by 
phagocytosis. Macrophage cells then mediate destruction and elimination of the pathogen. 
Leishmania has adapted to live inside the macrophages and resist these killing mechanisms. 
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2.1 Macrophage receptors 
2.1.1 Mannose receptor: 
Mannose receptor is a membrane glycolipid expressed in high levels on tissue 
macrophages. It binds sugars including 1-fucose, D-mannose, and D-galactose, which are 
more common on the surface of microorganisms (229). The expression of this receptor is 
regulated, in part, by immunoglobulin receptors (213) and cytokines. For example mannose 
receptor is up-regulated by IL-4 (231) and IL-13 (57) but downregulated by IFN-y (92). 
Ligation of the receptor results in the release of lysosome enzymes in culture (179), 
production of reactive oxygen intermediates (17), cytokines (218,230) and upregulation of 
Fc receptors (171). 
Different Leishmania species were found to use mannose receptor for invasion of 
macrophages including L. donovani (35,36, 38,257), L. amazonensis (196) and L. mexicana 
(187). 
2.1.2 Complement Receptors (CR) 
The complement system is activated by three pathways; 1) classic pathway which is 
dependent upon antibody and the first complement components (Clq, Cls, and Clr), 2) 
alternative pathway activated by microorganism directly and binds C3 on the surface of the 
pathogen and 3) the lectin pathway which requires mannose binding protein (MBP). 
Macrophage complement receptors include CRI (CD35), CR3 (Macl, CDl lb/CD 18) and 
CR4 (CDl lc/CD18) all of which have been implicated in Leishmania macrophage invasion 
(66). CR1 is a monomelic receptor that bind C3b and C4b (128). Although it has been shown 
that Leishmania promastigotes opsonized with C3b are internalized by macrophages through 
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this receptor (46,66,67), a minimal role was found for CRlin internalizing L. amazonensis 
(166). 
CR3 is a heterodimer that binds to iC3b. Leishmania was reported to bind CR3 either 
by opsonization with iC3b or through direct binding of the receptor to gp63 and LPG on the 
surface of promastigotes (88,124,167,207,238). Although both L. major and L. 
amazonensis promastigotes were shown to bind to CR3 (167), only a minimal role for this 
receptor was reported in L. amazonensis (166) and L. mexicana (187) amastigote 
internalization. CR4 was found to bind to a lesser extent to both L. major and L. amazonensis 
(5). 
2.1.3 Scavenger receptor 
Scavenger receptor binds to and internalizes both lipoproteins and 
lipopolysaccharides (LPS). There are two members of this receptor family that have been 
shown to bind microbes; Scavenger receptor A (SR-1) and MARCO (macrophage receptor 
with collagenous structure) (186). There are no reports for the involvement of these receptors 
during Leishmania internalization. Although apoptotic cells were found to be internalized 
through this receptor leading to enhance Trypanosoma cruzi growth inside the macrophages 
(74). This receptor might play a role in Leishmania internalization in vivo. 
2.1.4 Lectin-Iike receptors 
There are wide varieties of surface lectins that mediate detection of self- and foreign-
carbohydrates including hexoses, glucose, fucose, and mannose (253). These receptors were 
found to be responsible for 50% of the binding of L. major amastigotes and promastigotes to 
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resident macrophages, but only 10% of the binding to activated macrophages (165). The role 
of lectin-like receptors in binding L. braziliensis and L. donovani promastigotes to 
macrophages was demonstrated in the absence of serum (19,100). 
2.1.5 Fc receptors 
FcR are a group of receptors which recognize the Fc portion of immunoglobulins 
each antibody class has their own specific receptor. FcyR binds IgG, FcaR binds IgA, FCER 
binds IgE, FcjxR binds IgM,and FcôR binds IgD. FcyR is further divided according to the 
isotype of IgG that is recognized by the receptor. FcyRI binds IgG2a, FcyRIIb or FcyRIIa 
only in humans, binds IgGl, and FcyRIII binds both IgGl and IgG2a (106). Two forms of Fc 
receptors are found, soluble forms and membrane bound forms (47). Soluble forms are a 
result of proteolytic cleavage of FcyRII and III or through alternative splicing and have been 
reported to cause an inhibition of B cell proliferation and immunoglobulin production. 
Soluble forms also are thought to decrease antigen presentation in macrophages and DCs (75, 
77). The FcR also divided according to their affinity of antibody binding: low affinity 
(FcyRII and FcyRIII) and high affinity (FcyRI, FceRI, and FcaRI). Both low and high 
affinity receptors induce FcR aggregation, but the difference between the two types is just in 
the order of interaction. Low affinity receptors a need antibodies to complex with antigen 
first then bind to the receptors through low avidity, while high affinity receptors bind the 
monomelic antibodies first and then complex with antigen which leads to receptor 
aggregation (47,198). 
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After Fc receptors bind antibody and aggregate they transmit downstream signals to 
either activate macrophage function through the cytoplasmic signaling domains of the 
receptors termed immunoreceptor tyrosine-based activation motifs (ITAMs) associated with 
either the y or Ç chain, or they inhibit macrophage function through immunoreceptor tyrosin-
based inhibitory motifs (ITIMs). ITAM containing Fc receptors include FcyRI, FcyRIII, 
FceRI, and FcaRI. Only FcyRIIb contains an ITIM motifs despite this, it the most abundant 
Fc receptor expressed on cells (106). Signaling through IT AM motifs results in endocytosis, 
phagocytosis, antibody dependent cellular cytotoxicity (ADCC) and production of 
inflammatory mediators, while signaling through ITIM motifs inhibits all of these activities 
(183). 
Phagocytosis through Fc receptors requires a FcRy chain (52). Phagoctosis of 
antibody-coated particles was abolished in macrophages deficient in FcRy chain (237), but 
FcyRIIb missing the y chain was shown to mediate phagocytosis of opsonized particles in 
macrophages and CHO cells transfected with FcyRIIb (96,118). 
Leishmania has been shown to use the Fc receptor to bind to and invade macrophages 
after antibody opsonization through phagocytosis (88,99,126,166,187). The necessity for 
Fc receptor in Leishmania persistence was demonstrated in FcRy-receptor deficient mice and 
antibody deficient mice (27,44,126,158). The mechanism Leishmania Fc receptors use for 
intracellular survival remain under debate, as it has been shown that in the absence of Fc 
receptor there is less phogocytosis and less recruitment of immune cells to the site of 
infection. This may be due to decreased antigen presentation (44), other reports have showed 
a role for Fc receptor and antibody opsonization in IL-10 production and subsequent 
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suppression of macrophage activation (27,122,158). Taking in consideration the differences 
between Leishmania species and the variant mouse strains used in these experiments, these 
results emphasize the fact that Leishmania uses these receptors for invasion and survival. Fc 
receptor signaling is not only a source of host-immune response resistance for the parasite 
but also could be as a source for macrophage activation and control Leishmania infection 
(50). 
2.2 Phagocytosis 
After foreign antigen binds a macrophage receptor, a clustering of the receptors lead 
to localized actin polymerization at the site of particle phagocytosis (85). Recruitment of 
receptors to the site of particle binding is required for actin dependent engulfment of the 
particle (129). After phagocytosis and vacuole formation, the vacuole undergoes maturation 
to form a phagolysosome. The first step in endosome maturation is formation of a endosome 
(early endosome), which is recognized by the presence of Ras-associated GTP-binding 
protein 5 (Rab5) and early endosome antigen 1 (EEA1). From there, the endosome is directed 
to form a recycling endosome expressing Rabl lor directed to mature into a late endosomes 
responsible for degradation. Late endosomes are acidic (pH 5.5) and have of Rab7, Rab9, 
mannose 6-phosphate receptor and lysosomal-associated membrane proteins (LAMP) 
expression. The final step of maturation is the formation of lysosomes, which are more acidic 
(pH< 5.5), with active lipases and proteases like cathepsin D and they contain LAMPS (247). 
Leishmania live within parasitophorous vacuoles (PVs) inside the macrophages 
which vary in the size dependent on the species of the parasites. L. amazonensis and L. 
mexicana live in large communal PVs, whereas L. major and L. donovani live in tight 
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individual PVs (7). PVs are intracellular compartments surrounded a membrane enriched 
with late endosomal /lysosomal markers including Rab7, macrosialin, LAMP1, LAMP2 and 
vacuolar H+-ATPase. A poor fusion between the phagosme and lysosome in macrophages 
infected with L. donovani promastigotes was found due to LPG effect (59), however, both L. 
amazonensis and L. major were reported to induce phagosome and lysosome fusion within 
30 min to form late endosomes. L. amazonensis amastigotes were found to induce the large 
PVs in much shorter time than promastigotes (45), as shown in previously (discussed in PPG 
section) these large PVs are thought to be due to the sPPG. 
2.3 Macrophage killing mechanisms 
2.3.1 Respiratory burst: 
Respiratory burst is a potent antimicrobial response induced by the formation of 
reactive oxygen species intermediates (ROS) (63). Different sources for ROS are reported 
including; iNOS, NADPH oxidase, cyclo/oxygenase, lipoxygenase, xanthine oxidase, and the 
mitochondrial electron transport chain (70). Under inflammatory conditions the main sources 
of ROS are NADPH oxidase and xanthine oxidase (206). NADPH oxidase has five protein 
subunits (gp91, p22, p40, p47 and p67), that are assembled on the inner surface of the plasma 
membrane upon activation and react with NADPH as a substrate which in turn reduces 
oxygen to superoxide (48,219). After superoxide is produced, it spontaneously, through 
enzyme catalysis, produces hydrogen peroxide, hydroxl radicals, hypochlorous acid and 
peroxynitrite (in the presence of NO) (115). Both IFN-y and TNFa are important for priming 
NADPH oxidase (65,212,242). Cross-linking of FcyRI can also mediate the activation of 
20 
NADPH oxidase through protein kinase C (PKC) cell signaling via FcR ITAMs motifs and 
Syk, a protein tyrosine kinase, Phosphatidylinositol 3-kinase(PI3K), phospholipase (PLC) 
and the release of Ca2+ (211,260). 
Superoxide is also produced by xanthine oxidase, which an enzyme produced by a 
wide range of cells with three active sites; flavin adenine dinucleotide (FAD), molybdenum 
(Mo) and cytochrome with haem iron. Xanthine oxidase can act as a peroxynitrite synthase 
as it has been shown to produce both nitric oxide by reducing nitrite to nitric oxide and 
superoxide by donating an electron from xanthine to oxygen. These two reactive compounds 
NO and superoxide, react together to produce peroxynitrite (159). Xanthine oxidase has been 
shown to be upregulated by various macrophages activation molecules; IFN-y, TNF-a, IL1 
and LPS (93). 
2.3.2 Nitric Oxides (NO) 
Inducible nitric oxide synthase (iNOS) is the enzyme responsible for NO production 
during an activated immune response and the presence of Ca2+ and calmodulin are needed for 
iNOS activity (258). L-arginine is the substrate from which iNOS obtains nitrogen to produce 
NO (101,176). Macrophage activation with either IFN-y or LPS induces the uptake of 
arginine and the upregulatation of iNOS (28,91). NO is microbicidal through different 
mechanisms including; protein nitrosylation, tyrosine nitration, inhibition of respiratory chain 
through inhibition of cytochrome oxidase, iron deprivation through binding of iron to an iron 
response element (IRE), inhibition of ribonucleotide reductase (RNR) which inhibits DNA 
synthesis, guanine oxidation that leads to DNA mutation, DNA strand degradation, DNA 
deamination and lipid oxidation (reviewed by (51)). 
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The importance of NO in Leishmania infection was demonstrated by the experiments 
in iNOS deficient mice which have exaggerated non-healing lesions after L. major infection 
61,250,62). The same results were also obtained with use of an iNOS inhibitor (140,232). 
Although the actual role for NO and iNOS for control of Leishmania infection is not clear, 
but it has been suggested that NO is cytostatic to Leishmania whereas peroxynitrite is 
cytotoxic (142). 
2.3.3 LOHA (N^hydroxy-L-arginine) 
LOHA is produced as an intermediate product after iNOS react with arginine to 
produce citrulline and NO. LOHA has been shown to inhibit arginase, an enzyme used by 
Leishmania to produce ornithine and urea from arginine. This inhibition of arginase prevents 
polyamine synthesis essential for Leishmania growth and as a consequence LOHA was 
shown to control L. major and L. infantum growth (114). 
2.3.4 Iron deprivation 
Iron deprivation is used by host macrophages to control microbial infection (251). 
Many different mechanisms promote iron deprivation including inhibition of ferritin, a 
protein used to store iron by the cells, binding of iron lactoferrin, a protein that bind iron at 
high affinity in low pH, and iron binding to transferring, a protein produced in activated 
macrophages to bind intracellular iron (254, 69,178). Treating macrophages with LPS and 
IFN-Y induces NO production and activates iron regulatory protein (IRP) to repress firritin 
translation through reducing intracellular iron stores and decreasing iron availability (200) 
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(254). Natural-Resistance-Associated Macrophage Proteins (NRAMP) act as divalent 
metal/proton co-transporter proteins. There are two forms of these proteins NRAMP- 1 and 
NRAMP-2 (72). Both of them are upregulated in response to LPS and IFN-y (83). These 
proteins were shown to play a major role in resistance to Leishmania infection, as resistant 
mouse strains that have a mutation in NRAMP are susceptible (246, 84). NRAMP was shown 
to have a role in the phagolysosome fusion in L. major infected macrophages (216). 
NRAMP 1 is known to regulate a cascade of genes including TNFa, MHCII and IL-1 (3 (222). 
2.3.5 Tryptophan degradation 
Tryptophan is the least available amino acid for metabolism (181). 
Indoleamine 2,3dioxygenase (IDO) is an enzyme found in tissue which degrades tryptophan. 
IDO was found to be induced by IFNy and augmented by TNF-a or LPS (255). There is no 
direct link between tryptophan degradation and the control of Leishmania to date although 
addition of external tryptophan increased Leishmania replication (172). 
2.4 Leishmania evasion of macrophage activation 
2.4.1 Antigen presentation and co-stimulatory molecule 
Antigen presenting cells (APC) including macrophages, DCs, and B cells present 
antigen on surface of major histo-compatibility complex class II (MHCII) receptors to T cells 
inducing the T cells to become activated and proliferate. For Thl cells to induce 
macrophages to control intracellular pathogen infection proper co-stimulatory molecule 
expression is necessary. These receptor ligand interactions include co-ligation such as CD40 
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with CD40L (on T cells) (20). L. donovani was found to suppress the expression of MHCII 
(201) while both L. amazonensis (192) and L. major (76) suppress antigen loading on 
MHCII. L. amazonensis amastigotes were found to internalize and degrade MHCII by 
parasite cysteine peptidases (54). The parasite has also been shown to sequester antigen 
within the phagolysosome thereby preventing antigen presentation to CD4+ T cells (127). 
CD40/CD40L interactions were found to be necessary for control of L. major infection in a 
murine model of cutaneous disease (31,224). L. donovani induced a five fold suppression of 
CD40 expression (25) which caused secondary inhibition of macrophage activation. 
2.4.3 Modulation of cytokine secretion 
2.4.3.1 Inhibition of IL-12 production 
IL-12 is a critical cytokine for induction of a Thl immune response through T cell 
activation and induction of IFN-y production. BALB/c mice, susceptible to L. major 
infection, become resistant after treatment with IL-12 (98,233). Mice resistant to L. major 
became susceptible when IL-12 was depleted with mAb (149). Infection with either L. 
donovani, L. major, L. mexicana and L. amazonensis was found to suppress IL-12 
production (32,252,15, 117). 
2.4.3.2 Induction of IL-10 and TGF-($ 
IL-10, a cytokine produced by a wide range of immune cells has been shown to 
suppress Thl responses and augments Th2 mediated immune responses. IL-10 inhibits 
macrophage activation, antigen presentation, co-stimulatory molecule expression and 
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production of IL-12 and TNF-a (163). L. donovani was found to induce IL-10 mRNA 
expression 16.5 fold in infected macrophages (156). Ligation of FcyR were found to induce 
IL-10 production in both L. major and L. mexicana infection (27,122,158), and IL-10 
deficient mice were resistant to infection with either L. major or L. mexicana (27,177). 
However IL-10 deficient mice infected with L. amazonensis were not found to be different 
from wild type mice in lesion size or parasite load (119), indicating that although L. 
amazonensis and L. mexicana are related, immune responses to these two species of 
Leishmania are different and IL-10 does not play a role in L. amazonensis persistence. 
TGF-p is another immunoregulatory cytokine shown to inhibit macrophage 
activation as well as IL-2 and IFN-y production from T cells (64, 243). L. amazonensis was 
found to increase TGF-P production through exposing phosphatidylserine (PS) on the 
amastigotes surface which binds a ligand on the macrophage and triggers TGF-P secretion 
(53). Different Leishmania spp. were reported to induce TGF-P production to evade 
macrophage activation including; L. amazonensis, L. tropica, L. chagasi, L. donovani and L. 
major (241, 78, 138, 12, 13, 199). TGF-P similar to IL-10 as it is used by the immune system 
as negative feed back to regulate the immune response, Leishmania spp. use these cytokines 
to attenuate the immune system and evade macrophage killed. 
2.4.4 Intracellular signaling 
2.4.4.1 Activation of cellular phosphatases 
Small heterodimer partner-1 (SHP-1) is most prominent regulated phosphatase in 
macrophages. SHP-1 is a protein tyrosine phosphatase (PTP) that is been described as a 
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negative regulator of tyrosine phosphorylation and signaling transduction (174). L. major and 
L. donovani infected mice treated with a FTP inhibitor demonstrated enhanced control of 
infection, as evident by a significant reduction in L. major lesion size, and complete protection 
against L. donovani (180). SHP-1 deficient mice did not develop lesions and when low 
numbers of parasites were recovered they were infected with L. major (73). This suggests that 
Leishmania activates cellular phosphatases to inhibit macrophage activation. 
2.4.4.2 Inhibition of Protein Kinase C (PKC) 
PKC is related to a family of serine/threonine kinases which participate in several 
cell-signaling pathways including phagocytosis through CR3 and FcR, phagolysosome 
fusion, oxidative burst and induction of inflammatory mediators (164,261,139). Leishmania 
spp. have been reported to inhibit PKC (228,105). LPG, GIPL and GPI have all been 
implicated as possible parasite molecules involved in this inhibition (40,18,236,155). 
2.4.4.3 Mitogen-activated protein Kinase (MAPK) 
The MAP kinases are a family of kinases responsible for activating many different 
macrophage functions. This family is composed of ERK, p38 and JNK/SAPK (43). The effect 
of Leishmania infection on the MAPK activation varies depending on the species and stage of 
the parasite and the cell type used for infection. L. amazonensis amastigotes were found to 
inhibit ERK1 induction in peritoneal macrophages through Leishmania PTP (145), L. 
donovani and L. major attenuated phorbol myristate acetate (PMA) induced MAPK (175, 87). 
A study in which macrophages are infected with L. mexicana amastigotes showed degradation 
of ERK and JNK but not p38 MAPK by parasite cystine peptidase (30). In contrast, LPG from 
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L. donovani was found to induce the activation of the three MAPK (10), while infection itself 
inhibited ERK activation through ceramide, sphingolipid precurser molecule (80). Another 
group recently showed a weak CD40 signal from macrophages infected with L. major 
promastigotes caused ERK phosphorylation and IL-10 production which inhibits further 
macrophage activation (146). Leishmania spp. appear to manipulate MAP kinases either by 
activation or inhibition in a manner that would help parasite survival within the macrophages. 
2.4.5 Peroxidoxin 
Peroxidoxins, also known as peroxiredoxins and thiol-specific antioxidants, are 
enzymes that detoxify hydrogen peroxide, hydroxy radicals and peroxynitrite (24). L. major, 
L. infantum and L. chagasi have been shown to produce peroxidoxins (137, 33,11). 
Peroxidoxins are produced by Leishmania spp. to protect themselves from RNS and ROS 
damage produced by macrophages and therefore evade macrophage killing. 
2.4.6 Superoxide dismutase (SOD) 
SOD is an enzyme produced by the cells to protect themselves from the superoxide 
they produce during oxidative burst. This protection is mediated by dismutating superoxide 
to form 02 and H202. Several Leishmania spp. have been shown to produce SOD themselves 
including L. chagasi, L. tropica and L. donovani (157, 170,184, 81). SOD-deficient 
Leishmania have reduced survivability inside macrophages and more sensitivity to hydrogen 
peroxide in culture (81). SOD produced by Leishmania is one of the mechanisms where the 
parasite avoids superoxide cytotoxicity. 
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2.4.7 Glutathione 
Glutathione is a thiol produced by both host cells and Leishmania parasites. Both host 
cells and parasite produced glutathione plays a role in detoxifying NO and protecting 
Leishmania from NO cytotoxicity (204). 
3. Host immune response to Leishmania 
A protective immune response to Leishmania infection is mediated through induction 
of productive cell-mediated immune response. Many cell types have been reported to 
participate in this immune response against Leishmania infection both negatively and 
positively. The primary cells types described as inducers of macrophage activation are CD4+ 
T cells and to a lesser extent CD8+ T cells. Antigen presenting cells ( APCs) and in particular 
dendritic cells are necessary for antigen specific T cells to be activated and proliferate. Two 
phenotypes of CD4+ T cells have been identified; T helper 1 (Thl) and T helper 2 (Th2). 
C3H, C57BL/6 and C57BL/10 mice mounting a Thl response, characterized by IL-12, TNF-
a, and IFN-y production, heal L. major infection. BALB/c mice that mount a Th2 response, 
with high levels of IL-4, IL-10, and IL-13, develop an exaggerated non-healing lesion when 
infected with L. major (248). 
3.1 CD4+ T cells and L. major infection 
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CD4+ T cells are the primary source of IFN-y, which is known to activate the 
macrophages to kill intracellular parasites (97). Mice deficient in IFN-y or treated with 
antibodies against IFN-y cannot heal L. major infection and subsequently mount a Th2 
response (132, 214, 249). When IFN-y is injected into susceptible mice the mice develop 
smaller lesions and mount a Thl response (239,214). Other cytokines including IL-12, 
produced by DCs, macrophages, neutrophils, and B cells, induce CD4+ T cells to produce 
IFN-y and induce a Thl response (240). The receptor for IL-12 has two subunits IL-12R|31 
which binds IL-12 and IL-12R|32 which is responsible for signaling transduction in the cell 
(240). Mice lacking either IL-12 or the IL-12 receptors cannot heal L. major infection and 
usually mount a Th2 response (149, 148,185, 34). Injecting IL-12 into susceptible mice at 
the time of L. major infection can induce healing with a shift to IFN-y production and a Thl 
response (98,185,233). In addition to IL-12 activation and MHCII presentation, co-
stimulatory molecules including CD28 expressed on T cells and their ligands B7.1 and B7.2 
expressed on DC and macrophages play an important role in CD4+ T cell activation (37). T 
cell expression of CD40 ligand which binds to CD40 on DCs has been found to play a crucial 
role in IL-12 production from the DC population (86). Direct contact between the CD4+ T 
cells with macrophage MHCII were not necessary for activation of macrophages and control 
of L. major in vivo ( 135). 
CD4+ T cells are responsible for production of Th2 cytokines including IL-4, IL-10, 
produced also from macrophages, and IL-13. In susceptible mice, a population of CD4+ T 
cells that are V|34"Va8+ and recognize L. major LACK antigen was shown to be responsible 
for IL-4 production (133). Early IL-4 production directs the immune response toward a Th2 
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response by inhibiting IL-12 production and downregulate IL-12R|32 expression on T cells 
(131), (102),(133). Susceptible mice treated with an anti-IL-4 antibody heal L. major 
infection (39,143, 210). IL-10 is known to inhibit macrophage activation and susceptible 
mice lacking IL-10 or depleting IL-10 with anti-IL-10 antibody will heal L. major infection 
(177,122). 
3.2 CD4+ T cells and L. amazonensis 
Contrary to the Thl/Th2 immune response paradigm defined by L. major for 
determining resistance or susceptibility to infection, the susceptibility of mice to L. 
amazonensis has been shown to be a result of an absence of either Thl or a Th2 response as 
significantly low levels of both IL-4 and IFN-y are detected after infection (1,116,120). 
Additional support for this assessment is that IL-4 deficient C57BL/6 mice remain 
susceptible to L. amazonensis infection. In these mice, IL-12RJ32 suppression was detected; 
obviously independent of IL-4 mediated suppression (120). IL-10 deficient mice also cannot 
heal L. amazonensis infection (119, 182). Although anti-TGF[3 or anti-IL-4 also induces a 
reduced lesion size of infected BALB/c mice, high parasite load was still detected in the 
lesion (12,2). Together these results indicate a minimal role for Th2 cytokines in promoting 
susceptibility to L. amazonensis infection therefore suggesting the role of alternative immune 
evasion strategies utilized by this parasite to survive intracellular macrophages killing. 
When RAG-2 deficient C57BL/6 mice that contain no T cell are infected with L. 
major, they develop exacerbated lesions (160), while infection of these mice with L. 
amazonensis induces only a very small lesion with a very low number of parasites present in 
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the lesion (223). A recent study showed increased replication of L. amazonensis amastigotes 
in the presence of IFN-y (194). This indicates not only is the immune response to L. 
amazonensis infection reduced in its Thl response, but the parasite uses Thl cytokines 
specifically to promote virulence in vast contrast to the situation during L. major infection. 
3.3 B cells 
B cell function in the immune system is a reflection of the humoral immune system 
and previously thought to primarily reflect a Th2 response, although B cells role in cell 
mediated immunity is not neglected. In addition to B cells role in secreting antibody, they are 
an APC through using MHCII and secret multiple cytokines including IL-12. The role of B 
cells in Leishmania infection has been studied using different mouse strains and different 
Leishmania species with various results for their specific role as APC or the role of secreted 
antibodies from B cells. 
Contradictory reports for the role of B cells in L. major infection range from B cells 
being not necessary to necessary for healing of infection. B cells were reported to be not 
necessary for healing in SCID mice reconstituted with CD4+ T cell from healed L. major 
infection (245,4). Infecting B cell-deficient BALB/c or C57BL/6 mice with L. major did not 
have a different disease out come from wildtype mice (44,23). Other reports indicate a role 
for B cells in Leishmania susceptibility including studies using BALB/c mice lacking B cells 
(104,209) or a study which converted T cell-reconstituted, resistant SCID mice to 
susceptible after co-transfer of B cells (103). Only in one study using C3H mice B cells were 
found to be necessary, where B cells were shown to be needed to induce proper T cell 
generation and healing of the infection (215). The B cells role is obviously linked to the role 
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of antibody in Leishmania virulence. This is discussed in the Fc receptors section of the 
introduction. 
The role for B cells during infection with L. mexicana complex parasites, L. 
mexicana, L. amazonensis, and L. pifanoi, is linked to the necessity for antibody for parasite 
invasion as discussed previously in the Fc receptor section (44,126). Opsonized L. mexicana 
induces IL-10 which further suppresses macrophage activation (27). In summary, these 
studies showed mostly either a negative or no role for B cells in protective immune response 
to Leishmania infection. 
4. General conclusion 
Despite the fact that the main role of macrophages in the immune system is to engulf 
pathogens and kill them, parasites such Leishmania manage to survive and live inside these 
macrophages. Leishmania has developed multiple different strategies to survive within the 
host. Some of these strategies are unique to each Leishmania spp., even within genetically 
related species, e.g. with the L. mexicana complex there are variations in the parasites 
interaction with the host immune system. As an example of these strategies, macrophages are 
equipped with surface receptors to detect foreign antigen, Leishmania use this system via 
surface molecules which allow the parasite to be detected and engulfed quickly and hide 
inside the macrophages and thereby to evade being killed by the complement system. Surface 
molecules of Leishmania change with the developmental stage of the parasite, as they need to 
be protected from the harsh environment inside the insect gut and from the first contact with 
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the blood, promastigotes have specific surface molecules that help them attach to the insect 
gut and the same time prevent their lysis by serum. Amastigotes have fewer surface 
molecules which specifically prevent activation of macrophages while reproducing inside the 
mammalian host. 
Macrophages need to be activated to kill intracellular Leishmania. This activation is 
linked to the production of Thl cytokine including IFNy which induces macrophages to 
secrete digestive enzymes, RNS, and ROS to kill Leishmania. Many species of Leishmania 
have developed means to induce a Th2 response and inhibit a Thl response, as seen during L. 
major infection. L. amazonensis induces a different immune response where there is an 
absence of either a Thl or Th2 responses. Even when a Thl response is induced, L. 
amazonensis parasite still resists macrophage activation. This indicates the complexity of L. 
amazonensis mechanism to resist macrophage activation and killing in the environment 
where other Leishmania spp. are killed. This macrophage survival mechanism of L. 
amazonensis may explain why L. major infection is usually a self-limiting disease while L. 
amazonensis produces a persistent chronic lesion. The understanding of this resistance by L. 
amazonensis to macrophage killing compared to L. major is the center of the work many 
research groups and will be the focus of this thesis. 
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CHAPTER 2 
Macrophage killing of Leishmania amazonensis amastigotes 
requires both nitric oxide and superoxide 
To be submitted to American Journal of Tropical Medicine and Hygiene 
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ABSTRACT 
The lack of understanding of the requirements for effective and efficient intracellular 
Leishmania amazonensis killing by activated macrophages has been a barrier to vaccine 
development against this parasite. Here we report using inhibitors of superoxide and 
inducible nitric oxide synthase that the presence of both superoxide and nitric oxide is 
necessary for killing of L. amazonensis amastigotes within LPS/IFN-y activated bone 
marrow-derived macrophages generated from C3H mice. Nitric oxide alone was sufficient to 
control L. major infection, as addition of a nitric oxide donor was sufficient to control L. 
major but not L. amazonensis infection. Addition of an extracellular signal-regulated kinase 
(ERK) inhibitor to L. amazonensis-infected macrophages increased the ability of these 
activated macrophages to kill L. amazonensis amastigotes. This enhanced macrophage killing 
through addition of ERK inhibitor was abrogated by inhibition of superoxide or iNOS, 
indicating that ERK activation may modulate effective macrophage killing lending to the 
ability of Leishmania amazonensis to resist elimination within activated macrophages. 
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INTRODUCTION 
Upregulation of inducible nitric oxide synthase (iNOS) has emerged as being 
important for leishmanicidal activity of infected macrophages 1,2,\ Evidence indicates that 
the anti-parasitic activity of this enzyme involves generation of reactive nitrogen 
intermediates; nitric oxide and/or other reactive nitrogen molecules4. These reactive nitrogen 
species may, in turn, interact with NADPH-oxidase dependent superoxide to produce or 
enhance cytotoxic responses (reviewed in5). Recent reports suggest that the contribution of 
NADPH-oxidase-dependent superoxide production to a leishmanicidal response may vary 
between different cell types and stage of infection2'6. In addition to nitric oxide production, 
the iNOS generated arginine metabolite Nw-hydroxy-L-arginine (LOHA) has been shown to 
limit the growth of Leishmania within infected macrophages and play a significant role in 
limiting in vitro infection rate1. 
Host intracellular signaling pathways are specifically targeted by the parasite during 
Leishmania infection to prevent a productive immune response (reviewed in8). Contradictory 
reports were shown for the role of mitogen-activated protein (MAP) kinases in the resistance 
of Leishmania to macrophage activation. As L. mexicana was shown to inhibit IL-12 
production through extracellular signal-regulated kinase (ERK) degradation9, both L. 
amazonensis amastigotes and L. donovani promastigotes were found to prevent ERK 
phoshorylation l0,u. On the other hand, Leishmania phosphoglycans were found to inhibit 
macrophage activation through ERK activation 12. L. major promastigote lipophosphoglycan 
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(LPG) has been shown to inhibit macrophage IL-12p40 production through extracellular 
signal-regulated kinase (ERK) activation 12. L. mayor-infected macrophages produce limited 
CD40-induced expression of IL-12p40 as a result of enhanced IL-10 production mediated 
through the host ERK pathway. However, LPG from L. donovani were found activate 
activation protein 1 (AP-1) through ERK l3.A variety of Leishmania spp. including L. 
amazonensis (reviewed in 14, *) have been shown to inhibit and/or resist macrophage 
activation, but the requirements for effective intracellular L. amazonensis killing by activated 
macrophages and the mechanisms involved remain unknown. 
We have focused our studies of L. amazonensis infection by using the C3H mouse 
strain as these mice are susceptible to infection by this parasite and yet resistant to the related 
parasite L. major. In particular, we have found that a previous infection with L. major limits 
disease upon subsequent infection with L. amazonensis indicating that C3H mice upregulate 
an effective anti-L. amazonensis immune response if activated appropriately. In this current 
work, we examined the capability of L. amazonensis amastigotes to prevent macrophage 
activation compared to L. major amastigotes infection in vitro by infecting first then induce 
the activation. In this system, both LPS and IFNg were chosen as a potent macrophage 
activator, as presence of IFNg prevents L. amazonensis inhibition of LPS induced iNOS 15. 
Under these defined pro-activation conditions, L. amazonensis amastigote parasites were not 
killed as efficiently as L. major amastigotes despite equivalent iNOS and nitric oxide levels. 
Unlike L. major, L. amazonensis was resistant to inhibition of replication mediated by 
LOHA, although replication of L. amazonensis was not a major factor in the ability of this 
parasite to persist within activated macrophages. L. amazonensis amastigotes were also 
shown to be resistant to the potentially leishmanicidal effects of the nitric oxide donor 
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(SNAP), indicating that although nitric oxide is sufficient to control L. major amastigote 
infection, additional factors are required for intracellular macrophage killing of L. 
amazonensis amastigotes. Addition of the ERK inhibitor PD98059 to activated macrophages 
promoted killing of L. amazonensis amastigotes, dependent upon the production of 
superoxide. ERK activation, therefore, may be a critical part of host cell signaling changes 
derived by intracellular infection with Leishmania amazonensis leading to an inadequate 
accumulation of multiple reactive oxygen species and promote intracellular parasite survival. 
These findings highlight the differences required for intracellular killing of disparate 
Leishmania species confirming that that the definition of an adequate host immune response 
against one Leishmania species does not apply to all parasites of this genus. 
MATERIAL AND METHODS 
Mice. C3HeB/FeJ and C3Smn.CB 17-Prkdasc,d/J (C3H scid) mice were obtained from 
Jackson Laboratory (Bar Harbor, Maine). Mice were maintained in a specific-pathogen-free 
facility. For the propagation of lesion derived amastigotes C3H SCID mice were infected 
with 5xl06 stationary-phase promastigotes in 50 ]A of PBS in the left hind footpad. All 
procedures involving animals were approved by the Committee on Animal Care at Iowa 
State University. 
Parasites. Leishmania major (MHOM/IL/80/Freidlin) and Leishmania amazonensis 
(MHOM/BR/OO/LTBOO16) promastigotes were grown to stationary phase in Grace's insect 
culture medium (Technologies, Gaithersburg, MD) with 20% heat-inactivated PCS, 2 mM 
glutamine, 100 U penicillin per ml, and 100 pig of streptomycin per ml. Amastigotes that 
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were used for in vitro infection were tissue derived and were harvested from lesions of C3H 
SCID mice as described I6. 
Cells and cell culture. Cells were obtained from the bone marrow of the mouse 
femur and tibia (15-20 x 106 cells) and plated in a 150 x 15 mm Petri dish with 30 ml of 
macrophage medium containing 30% L-cell conditioned medium, 20% PCS and 50% 
Dulbecco's modification of Eagle's medium (DMEM), 2 mM glutamine, 100 U penicillin per 
ml, 100 jig of streptomycin per ml, and 1 mM sodium pyruvate at 37 °C and 5% C02. After 2 
days another 20 ml of macrophage medium was added to the Petri dish. At day 7 the non­
adherent cells were removed and the plate scraped to harvest the adherent cell population. 
After washing with PBS, live cells were counted using trypan blue exclusion and 
resuspended in complete tissue culture medium (CTCM) containing DMEM, 10% PCS, 2 
mM glutamine, 100 U penicillin per ml, 100 //g of streptomycin per ml, 25 mM 4(2-
Hydroxyethyl)piperazine-l-ethane sulfonic acid (HEPES), and 0.05 /*M 2-(3-
mercaptoethanol. 
Macrophage infection and activation. BMM were plated in 24 well plates with 
glass cover-slips at a rate of 5xl05 cells/well, in 1 ml CTCM. After 24 h the BMM were 
infected with either L. major or L. amazonensis amastigotes at a 3:1 ratio and incubated at 
34°C for 24 h. The wells were washed two times with DMEM to remove extracellular 
amastigotes and a final volume of 1 ml CTCM was added. The macrophages were then left 
non-activated or activated with 100U/ml IFN-y and 100 ng/ml LPS (E. coli J5 from Sigma-
Aldrich, St. Louis, MO). For replication inhibition experiments, a concentration of 500 pM 
Nto-Hydroxy-nor-L-Arginine (LOHA, Calbiochem, La Jolla. CA) or 4 mM hydroxyurea (Alfa 
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Aesar, Ward Hill, MA) were used in each well of both activated and non-activated infected 
macrophages. Also, 15 piM Mn(III)tetrakis(4-benzoic acid)porphyrin chloride (MnTBAP, 
BIOMOL, Plymouth Meeting, PA), 100 p,M S-Nitroso-N-acetylpenicillamine (SNAP, 
Sigma-aldrich, St. Louis, MO), 1 mM L-N6-(l-iminoethyl)-lysine (1-NIL, A.G. Scientific, 
San Diego, CA) or 20 pM 2'-Amino-3'-methoxyflavone (PD 98059, Alexis, Lausen, 
Switzerland) were added at the time of activation. The cover-slips were removed, dependent 
on the experiments, after 24,48, and 72 h post-activation and stained using nonspecific 
HEMA 3 stain set (Fisher Diagnostics, Middletown, VA) and mounted on glass slides. 
Determination of the infection rate of macrophages and parasite count. Each 
individual coverslip was counted via light microscopy by examining 3 areas at lOOOx total 
magnification. In each area, 100 macrophages were examined and the number of infected 
macrophages and the number of parasites in each macrophage were counted. The average of 
the 3 areas was used to determine the percent of infected macrophages and the number of 
parasites per macrophage on each coverslip. 
Determination of nitric oxide. Nitrite concentrations were determined using the 
Greiss reagent as described previously 11. Briefly, equal volumes (50 }il) of cell culture 
medium and Greiss reagent (LabChem, Pittsburgh, PA) were mixed and incubated at room 
temperature and the absorbance was measured at 550 nm with a microplate reader 
(Molecular Devices, Sunnyvale, CA). The nitrite concentration was determined using a 
standard curve generated with sodium nitrite. 
Western blot. Twenty four hours after activation the macrophages were washed two 
times with 1ml PBS, then 100 nl of washing buffer was added (0.32 M sucrose, 3 mM 
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calcium chloride, 2 mM magnesium acetate, 0.1 mM EDTA, 10 mM Tris (Hydroxyethyl) 
aminomethane (Tris) (pH 8.0), 5 mM sodium fluoride, 1 mM dithiothritol (DTT), 0.5 mM 
phenylmethanesulfonyl fluoride (PMSF), 0.1 mM sodium orthovanadate and 20 pil per ml 
protease inhibitor cocktail (Sigma, St. Louis, MO). Then 100 [il of lysis buffer was added 
(wash buffer plus 1% nonidet P-40). The suspension was centrifuged at 2500 g and the 
supernatant was stored at - 80 °C. Protein concentrations were measured via BCA 
(bicinchoninic acid) protein assay (Pierce, Rockford, IL) using BSA as a standard. The 
cytoplasmic extracts were separated using 8% PAGE and transferred to nitrocellulose 
membrane using a semi-dry blotting apparatus from Bio-Rad (Hercules, CA). The membrane 
was blocked with 5% nonfat dry milk in PBS 0.1% Tween. Rabbit polyclonal anti-mouse 
iNOS (Upstate, Lake Placid, NY) was hybridized to the membrane overnight at 4 °C at a 
1:5000 dilution. The membrane was then washed and hybridized to a secondary goat anti-
rabbit conjugated to hydrogen peroxidase (Jackson ImmunoResearch, West Grove, PA) at a 
1:50,000 dilution, and the signal was detected using the Pierce Supersignal Reagents (Pierce, 
Rockford, IL) as directed by the manufacturer. The membranes were rehybridized with a 
rabbit polyclonal anti-mouse actin Ab at a 1:500 dilution (Sigma, Saint Louis, Missouri) as 
described above. 
ELIS A for IL-10. The level of IL-10 protein in supemates was determined by 
ELISA according to the manufacturer's instructions (Pharmingen, San Diego, CA). 
Statistics. Data analysis was performed by using Statview 5.0.1 (SAS, Cary, NC). 
Statistical significance was determined by either Scheffe's test for pair wise comparisons 
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when comparing between parasite species or a paired t-test when comparing treatment groups 
within a parasite species as indicated in the figure legend. 
RESULTS 
L. amazonensis amastigotes are resistant to killing by IFN-y /LPS induced 
macrophage activation. To determine whether there is a relative resistance of L. 
amazonensis amastigotes to killing by macrophages with a defined activation stimulus, BMM 
derived from C3H mice were infected first with L. amazonensis or L. major amastigotes and 
then stimulated 24 h later with LPS and IFN-y. A disparate parasite survival response was 
detected three days post stimulation, as L. amazonensis maintained a high infection rate of 
86% of non-activated-infected control compared to 56% for L. major (Fig. la). There were 
no significant differences in nitrite accumulation between L. major and L. amazonensis-
infected, activated macrophages at any time point observed, indicating that nitrite production 
did not determine the difference in macrophage killing of L. major as compared to L. 
amazonensis (Fig. lb). Western blot analysis confirmed equivalent iNOS protein expression 
in uninfected, L. amazonensis infected, and L. major infected macrophages at 24 h post-
LPS/IFN-Y activation (Fig lc). 
The numbers of parasites per infected macrophage were counted to determine if 
macrophage activation influenced the in vitro intracellular growth of the L. amazonensis 
parasites. The results in Figure Id show that under activation conditions both species had a 
significant reduction in the number of parasites per infected macrophage at day 3 post-
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activation. However, in both the control and activated groups there were relatively more L. 
amazonensis parasites per macrophage than corresponding L. major infected cells (control = 
9.82 + 2.52 and 3.92 + 0.88, respectively; activated = 4.7 + 0.55 and 1.86 ± 0.12, 
respectively). 
L. amazonensis amastigotes are resistant to the growth inhibitory effects of 
LOHA, although replication plays a minimal role in L. amazonensis amastigote survival 
in vitro. Recent studies have demonstrated that for L. major the infection rate of 
macrophages in vitro was partially dependent on the ability of the parasite to replicate within 
the infected macrophages 18. Therefore L. amazonensis persistence despite relatively high 
levels of nitrite production and iNOS expression could indicate resistance to growth 
inhibitory effects of LOHA7. LOHA is an intermediate of NO generation by iNOS and an 
inhibitor of arginase activity. Arginase is an enzyme important for polyamine synthesis, a 
metabolic pathway necessary for parasite growth. We tested the hypothesis that L. 
amazonensis is resistant to LOHA allowing increased replication inside macrophages. LOHA 
(500 (xM final concentration) was added to cultures at the time of macrophage activation and 
the percent of infected macrophages and the numbers of parasites per infected macrophage 
were evaluated as previously described. L. major was sensitive to the effects of LOHA (Fig. 
2) as there was a significant decrease in the percent of macrophages infected with L. major as 
well as a reduction in the number of parasites per macrophage in the presence of the inhibitor 
under non-activating conditions (Fig 2 a and b). Under activation conditions there was a 
significant effect of LOHA as determined by a further reduction in the macrophage infection 
rate, although as the average number of parasites per macrophage was close to one no change 
in the number of parasites per macrophage could be detected (Fig. 2 c and d). In contrast, 
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LOHA had no effect on either of these parameters in L. amazonensis infected macrophages 
under non-activated or activated conditions (Fig 2). These results indicate that L. 
amazonensis is resistant to LOHA inhibition of replication and suggest that enhanced L. 
amazonensis replication during macrophage activation may maintain a higher rate of 
infection in the in vitro assay To then specifically test the effect of replication on the 
enhanced infection rate of L. amazonensis we used the DNA synthesis inhibitor hydroxyurea 
(4 mM final concentration)19. L. major survivability was again decreased, similar to the 
results seen with LOHA confirming a role for parasite replication in influencing the rate of 
macrophage infection with L. major in our in vitro system (Fig. 2). In contrast, although 
hydroxyurea did significantly reduce L. amazonensis replication, as seen as a decrease in the 
numbers of parasites per macrophage under non-activated conditions (Fig. 2b), this reduced 
replication rate had no effect on determining the percent of macrophages that remained 
infected with the parasite (Fig. 2 a). In addition, although the hydroxyurea mediated 
inhibition of replication did reduce the percentage of L. amazonensis infected macrophages 
under activated conditions (12% reduction) (Fig 2c) the differences between L. amazonensis 
and L. major under identical conditions were still dramatic. Altogether these results indicate 
that replication of the parasite plays a significant role in the persistence of L. major under 
both activated and non-activated conditions, while in contrast, although L. amazonensis is 
resistant to the growth inhibiting effects of LOHA, enhanced replication of L. amazonensis is 
not entirely responsible for the ability of this parasite to persist in activated macrophages 
compared to L. major. 
L. amazonensis amastigotes are resistant to NO. A previous study used the nitric 
oxide donor (SNAP) to investigate the effect of nitric oxide alone on L. amazonensis or L. 
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major promastigotes within infected macrophages and showed that both parasites were 
susceptible to killing mediated via nitric oxide20. Despite similar levels of nitrite (Fig. lb), 
our studies demonstrate a differential susceptibility between the two parasites suggesting that 
L. amazonensis amastigotes are more resistant to nitric oxide as compared to L. major 
amastigotes. Treatment of amastigote-infected macrophages with SNAP (100 pM) was 
sufficient to control L. major infection (Fig. 3a), but L. amazonensis remained resistant to 
SNAP with or without IFNy and LPS activation (Fig. 3a). To determine if nitric oxide was 
playing any role in limiting the L. amazonensis infection in vitro we inhibited iNOS using 1-
NIL (1 mM). There was an abrogation of the L. major killing and the L. amazonensis 
infection rate was significantly enhanced over the non-activated control (Fig. 3b). After 1-
NIL treatment there was also an increase in the number of intracellular L. amazonensis and L. 
major parasites per macrophage (data not shown). These findings indicate that L. major 
amastigotes are highly susceptible to NO produced by activated macrophages. In contrast, 
although NO contributes to some limitation of L. amazonensis amastigote survival during 
activation conditions, it does not kill L. amazonensis as efficiently as L. major. 
The ERK inhibitor PD98059 promotes superoxide dependent killing of L. 
amazonensis in activated macrophages. IL-10 has been described as a cytokine that can 
inhibit macrophage activation and is produced in response to infection by Leishmania 
parasites within infected macrophages under a variety of experimental conditions. To 
determine if higher levels of IL-10 were associated with the differential resistance of L. 
amazonensis in activated macrophages, IL-10 levels in the supernatant of the cultures were 
measured by ELIS A. No significant differences in the level of IL-10 between L. 
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amazonensis, L. major and uninfected macrophages were observed (data not shown). 
Recently, Leishmania has been shown to limit macrophage activation through activation of 
mitogen-activated protein kinase (MAP kinase) ERK2l'13. Although the effects of ERK 
activation have been associated with increased IL-10 expression, in these studies, we wanted 
to test if the ERK signaling pathway could play a role in limiting macrophage responses 
during L. amazonensis amastigote infection in vitro. Resistance of L. amazonensis to 
macrophage killing was significantly diminished in the presence of the ERK inhibitor 
PD98059 (20 piM) and the reduction of the infection rate when compared to the control 
(52.57+8.01, Fig. 4) was similar to that of L. major amastigotes within activated 
macrophages (Fig. 4). The ERK inhibitor alone did not affect the infection rate in non-
activated macrophages for both parasites (data not shown). As we have demonstrated no 
difference in iNOS and NO microbicidal pathways between L. amazonensis and L. major in 
our in vitro system, we hypothesized that other effector molecules were enhanced in the 
presence of PD98059. Therefore we co-treated the infected and activated cells with the cell 
permeable superoxide dismutase mimetic MnTBAP (15 JAM) to scavenge superoxide or 1-
NIL (1 mM) to inhibit iNOS. As seen in figure 4, enhanced macrophage killing of L. 
amazonensis established by the ERK inhibitor, was negated in the presence of the superoxide 
inhibitor although there was not significant (p= 0.065) decrease in the killing of L. major, the 
infection rate was 67% of the uninfected control. Again, both species of Leishmania killing 
were inhibited in the presence of iNOS with the ERK inhibitor. Neither MnTBAP nor 1-NIL 
alone has any effect on the macrophage infection rate in the absence of activation (data not 
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shown). Therefore, the ERK inhibitor PD98059 leads to an induction of superoxide and 
iNOS dependent killing of L. amazonensis parasites in infected macrophages. 
DISCUSSION 
Previous studies as well as the initial experiments shown here (Fig. 1) demonstrate a 
specific resistance of L. amazonensis parasites to macrophage-activated killing as compared 
to L. major 20,22,23. We have extended these studies and the results support a model 
suggesting that L. amazonensis amastigote killing is dependent upon both nitric oxide and 
superoxide production from activated macrophages whereas L. major amastigotes are more 
susceptible to killing primarily by nitric oxide alone. 
Other studies have demonstrated NO-dependent killing of L. amazonensis in activated 
macrophages, as determined by enhanced parasite DNA fragmentation24. However, the 
relative resistance of L. amazonensis amastigotes to IFN-y/LPS mediated macrophage 
activation was not dependent on a parasite induced inhibition of the iNOS-NO pathway in 
our studies (Fig. lb and c). The cellular and molecular targets of iNOS-mediated 
leishmanicidal activity are somewhat controversial and NO is not thought to act alone within 
the host macrophage during the leishmanicidal response. Inhibition of iNOS by 1-NIL 
increased the infection rate of activated macrophages for both parasites (Fig. 3b), agreeing 
with previous work demonstrating the role of iNOS in controlling Leishmania in vivo 1,2,3 
and in vitro (reviewed5). The significant increase in the macrophage infection rate to 130% 
of non-activated control with the L. amazonensis amastigotes by 1-NIL could be consistent 
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with a recently identified role for IFNy in enhancing parasite replication (if iNOS mediated 
NO production was inhibited (Fig. 3)25. 
Our results support the evidence that NO acts as a cytostatic agent against L. 
amazonensis. Other factors, including superoxide, are needed to produce peroxynitrite, which 
has been shown to be more potent in killing L. amazonensis amastigote parasites in vitro 4. In 
macrophages, peroxynitrite and its derivatives are thought to be generated primarily from the 
close association of NO and superoxide (reviewed in5). The lack of effect by NO alone on 
L. amazonensis survival was contradictory to results shown by Gomes20. This difference 
could be due to the use of a different dose of SNAP or to the different stage of the parasite 
(promastigotes vs amastigotes), macrophage type (peritoneal vs BMM) or mouse strain 
(CBA/J mice vs C3H). 
Low levels of induced CD40 signaling within L. major infected peritoneal 
macrophages were found to cause ERK phosphorylation, IL-10 upregulation and inhibition 
of IL-12 and iNOS production21. Here we show that the ERK inhibitor, PD98059, reduced 
the survivability of intracellular L. amazonensis in BMM via superoxide- and NO-dependent 
mechanisms (Fig. 4). The absence of differential expression of IL-10 in our system between 
L. major and L. amazonensis infection as determined by ELISA, was expected based on 
previously observed findings that IL-10 has been shown to inhibit production of both iNOS 
and NO 26,27. As neither iNOS nor NO are differentially produced between L. amazonensis 
and L, major infection, regulatory IL-10 production was also unlikely to be significantly 
different between these infections. While the actual relationship between superoxide 
production and ERK signaling is not yet known in our experimental system, it has been 
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previously shown that LPS-activated peritoneal macrophages induce Cu/Zn superoxide 
dismutase production through ERK activation28. These results support previous studies 
indicating a need for peroxynitrite to control L. amazonensis as a result of both superoxide 
and NO production 19. Although this relationship may also occur in macrophages infected 
with L. major amastigotes, we have demonstrated that the killing of L. major within activated 
macrophages is more directly related to the presence of nitric oxide and does not depend on 
the presence of superoxide (Fig. 4). 
Although we did not see significant differences in either nitrite production or iNOS 
protein expression levels (Fig. 1 b and c) after macrophage activation, there were consistently 
higher numbers of L. amazonensis amastigotes than L. major amastigotes within activated 
macrophages and an increased percentage of macrophages infected with L. amazonensis. 
Recent studies have demonstrated that not only is iNOS generated NO important for 
leishmanicidal activity, but also that LOHA (an intermediate of iNOS dependent NO 
generation) can have a direct effect in inhibiting the growth of Leishmania1. These previous 
studies demonstrated that both L. major and L. infantum were susceptible to the inhibitory 
effects of this compound at a concentration of 100 piM7. We found that in contrast to L. 
major, there was no growth inhibition of L. amazonensis at a LOHA concentration of 500 
jxM (Fig. 2). Although the exact mechanism of this resistance remains unknown, there are at 
least three different possible mechanisms of LOHA resistance. First, parasite derived 
arginases could be resistant to LOHA inhibition. Recent studies have shown that arginase 
from L. amazonensis was distinct from that of L. major and therefore these differences could 
provide L amazonensis-specific resistance to LOHA29. Secondly, L. amazonensis may 
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produce polyamines by other pathways, including arginine decarboxylase, shown to play a 
role in Trypanosoma cruzi metabolism30. Finally, L. amazonensis may have the capability to 
use host-derived precursors to polyamine synthesis more efficiently than L. major. These 
three alternatives provide means by which L. amazonensis may use to counteract the 
inhibitory properties of LOHA. 
Parasite replication has been previously demonstrated to correlate positively with the 
level of L. major infection using in vitro macrophage infection rates and our results with L. 
major amastigotes using both LOHA and hydroxyurea are consistent with these observations 
1
. Surprisingly, inhibition of parasite replication with hydroxyurea had only modest effects on 
limiting the infection rate of macrophages infected with L. amazonensis amastigotes (Fig. 
2c). The absence of any further reduction in the numbers of parasites per macrophage in 
activated macrophages with hydroxyurea would suggest that there is no significant 
replication of L. amazonensis occurring during these activated conditions. Again this 
supports previous studies suggesting NO is cytostatic for L. amazonensis, but not cytotoxic 4. 
Therefore replication of L. amazonensis was not responsible for the resistance of this parasite 
to macrophage activation when compared to L. major (Fig. 2). 
The studies presented here indicate that L. amazonensis amastigotes are resistant to 
host-mediated anti-leishmanial responses in non-inflammatory macrophages from C3H mice 
activated with the proinflammatory mediators LPS and IFN-y. Furthermore, we demonstrate 
several significant differences in the host-parasite relationship when L. amazonensis 
amastigotes and L. major amastigotes are directly compared in our in vitro assay. We have 
found that although L. amazonensis is resistant to the growth inhibitory effects of LOHA the 
parasite does not require enhanced replication or iNOS inhibition for enhanced survival 
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within the activated macrophages. While L. major amastigotes were killed primarily by NO 
alone, the anti-leishmanicidal response towards L. amazonensis amastigotes required both 
superoxide and NO production. Finally, these studies, implicate the ERK pathway as a host-
signaling pathway potentially central to influencing the host-pathogen relationship of these 
intracellular parasites, warranting further study. 
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Figure 1. Leishmania amazonensis amastigotes are resistant to killing by LPS/IFN-y 
activated macrophages. A. C3HeB/FeJ BMM were infected with L. amazonensis or L. major 
amastigotes and activated 24 h later with IFNy and LPS. At the timepoints post-activation 
indicated, the percent of the macrophages infected with parasites was determined. % of 
control = ((percent of infected macrophages in the activated cultures)/(percent of infected 
macrophages in the non-activated culture))xl00. The data shown are the mean + the standard 
error from 3 independent experiments with 2 replicates per experiment (*= p<0.05, Scheffe's 
test) B. Nitrite levels in supernatants of the cultures measured by the Greiss reaction. Results 
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are the average of 3 experiments with 2 to 3 replicates in each experiment. C. The level of 
iNOS protein in the cytoplasmic extracts of uninfected (U), L. amazonensis (LA), or L. major 
(LM) infected macrophages, was determined at 24 hours after activation via western blot 
analysis with an anti-iNOS antibody and re-hybridized to anti-actin. The results are 
representative of 3 independent experiments. D. The number of parasites per infected 
macrophage was determined 3 days after activation. The data shown are the mean + standard 
error from 3 independent experiments with 2 to 3 replicates per experiment. (*= p<0.05, 
paired t-test compared to control). 
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Figure 2. Leishmania amazonensis amastigotes are resistant to the arginase inhibitor N™ 
Hydroxy-nor-L-arginine (LOHA). C3HeB/FeJ BMM were infected and at 24 hours post­
infection left non-activated or activated as described in Fig. 1 and assayed for (A and C) the 
percent infected macrophages or (B and D) the number of parasites per macrophage. 500 //M 
LOHA (Gray bars) or 4mM hydroxyurea (black bars) was added to the appropriate wells at 
24 hours post-infection. Both figures A and B were under non-activation condition while 
figures C and D were activated with LPS and IFNy. The data shown are for day 3 after 
treatment and activation (*= p<0.05, paired t-test). The results shown are the mean ± 
standard error of 3 independent experiments with 2 replicates per experiment. 
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Figure 3. L. amazonensis amastigotes are resistant to NO within infected macrophages. 
C3HeB/FeJ BMM were infected as described in Fig. 1. At 24 hours post-infection (a) cells 
were either left non-activated with 100 piM SNAP (SNAP alone) or activated with IFN-y/LPS 
as in figure 1 (Activated) or activated with SNAP (Activated + SNAP), (b) cells were 
activated without (Activated) or withl mM 1-NIL (Activated + 1-NIL). The percentage of 
macrophages infected with parasites was determined after 3 days as described in figure 1. 
The data shown are the mean ± standard error from 2-3 independent experiments with 2 
replicates in each experiment. * indicates significant differences (p< 0.05, paired t-test). 
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Figure 4. The ERK inhibitor PD98059 promotes superoxide and iNOS dependent killing of 
L. amazonensis amastigotes. C3HeB/FeJ BMM were infected and activated with LPS/IFN-y 
as described in figure 1. At the time of activation the ERK inhibitor, PD98059 (20 mM), the 
cell permeable superoxide dismutase mimetic, MnTBAP (15 mM), or the iNOS inhibitor, 1-
NIL (1 mM), was added as indicated. The data shown are the mean ± standard error from 2-3 
independent experiments with 2 replicates in each experiment (* indicates a significant 
difference (p< 0.05, paired t-test), the letter (a) indicates significant difference (p< 0.05, 
paired t-test) with L. amazonensis infected BMM activated and treated with PD98059 alone 
and the letter (b) indicates significant difference (p< 0.05, paired t-test) with L. major 
infected BMM activated and treated with PD98059 alone. 
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CHAPTER 3 
Leishmania major specific CD4+ T cells and B cells limit L. amazonensis 
amastigote survival within in vitro infected macrophages through IgG 
mediated superoxide production 
A paper to be submitted to the Journal of Immunology 
Rami Mukbel, Christine Petersen and Douglas Jones. 
Department of Veterinary Pathology, College of Veterinary Medicine, Iowa State University, 
Ames, Iowa 50011. 
Abstract 
Infection of C3H mice with L. amazonensis results in a persistent lesion characterized 
by an immune effecter T cell phenotype that is neither a Thl or Th2 response, while infection 
with L. major results in a Thl response and a healed lesion by 8-10 weeks post-infection. 
Previous work from our lab has shown that a prior infection with L. major will protect 
against a subsequent challenge of L. amazonensis. We now show that draining lymph node 
cells (DLN) of L. major infected mice are able to limit both the percentage of macrophages 
infected with L. amazonensis amastigotes in vitro and the number of parasites per 
macrophage in an antigen-dependent manner. Depleting either CD4+ T cells or B cells 
abrogated the ability of the DLN cell population to control the infection, whereas depleting 
CD8+ or CD1 lb+ cells had a minimal effect. CD4+ T and B cells together were sufficient to 
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induce effective macrophage activation although direct contact between the lymph node cells 
and the macrophages was not necessary. Limiting secreted antibodies from the culture using 
anti-IgG/IgM coated beads significantly inhibited killing of the parasite in this experimental 
system. Inhibiting intracellular superoxide production with MnTBAP treatment caused a 
significant increase in L. amazonensis survival. In conclusion, ex-vivo derived CD4+ T cells 
and B cells from the DLN of L. major infected mice can activate macrophages to control L. 
amazonensis infection through antibody-mediated superoxide production. 
Introduction 
Infecting C3H mice with L. amazonensis results in a persistent, high parasitic load, 
and chronic lesion. Infection of these same mice with L. major results in lesion size peaking 
within 2-3 weeks, which is completely healed 8-10 weeks later. These differences in clinical 
presentation relate directly to the effectiveness of the immune response towards parasites and 
the characterization of the deficiency in the immune response to L. amazonensis and the 
mechanism to evade the immune system are the focus of many studies up to this point. In 
vivo, Leishmania amastigotes establish their infection within host macrophages and their 
survival is dependent in part on their resistance to macrophage-mediated killing. This 
resistance could be through direct effects of the parasite on the macrophage itself to inhibit 
activation or through their effect on other immune cell types that participate in the induction 
of macrophage activation and killing. 
Several studies have established a role for multiple cell types of the immune system 
in the immune response to Leishmania using either genetically altered mice or antibodies 
targeting a specific cell type in vivo (reviewed (1)). CD4+ T cells were identified as a key 
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cell type in controlling Leishmania major infection. Specifically, whether they induce 
healing and parasite control through a Thl response with high IL-12 and IFN-y and or a non­
healing Th2 response with high IL-10 and IL-4, also determined by the antigen specific 
CD4+ T cell response (reviewed (2)). However, the collective data up to now indicates that 
the production of a protective immune response toward L. amazonensis is not as simple as 
the presence of a Thl response. Vaccine designs using DNA or promastigotes gave some 
protection against L. amazonensis infection (3,4,5,6) but an antigen specific Thl response 
induced by either transferring a L. amazonensis Thl cell line to C57BL/6 mice (7) or 
injecting IL-12 and dendritic cells pulsed with L. amazonensis antigen to lesions of C3H 
mice infected with L. amazonensis (8), did not resolve the infection. However, a primary 
infection with L. major infection does induce a healing response after L. amazonensis 
challenge (9). Together these studies indicate that CD4+ Thl cells alone may not be able to 
control L. amazonensis infection although the immune response developed during a healing 
L. major infection can provide all necessary factors to resolve a secondary L. amazonensis 
infection. 
Contradictory reports exist for the role of B cells, antibody and antibody receptors in 
Leishmania infection. Most studies show lack of necessity for B cells and/or antibodies in 
healing and indicate a role of antibodies and Fc receptors in Leishmania cellular invasion 
(10). It has been also shown that internalization of antibody opsonized Leishmania induces 
IL-10, inhibiting macrophage activation (11,12, 13). Separate studies have demonstrated that 
activation of macrophages by IgG through Fc receptors in the presence of IFNy results in 
superoxide and hydrogen peroxide production, as well as nitric oxide production (14). 
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As we have found in previous studies that infection with L. major can limit a 
subsequent challenge with L. amazonensis, we tested the hypothesis that DLN cells from 
mice infected with L. major could control L. amazonensis amastigote infection of BMM in 
vitro. We found that CD4+ T cells and B cells from DLN of L. major infected mice were, 
together, in the presence of antigen capable of inducing BMM to control L. amazonensis 
amastigotes infection. Specifically, secreted factors from these cells were found to be 
responsible for the effective BMM activation. One secreted factor identified was 
immunoglobulin and the mechanism of parasite killing was superoxide dependent. These 
findings provide crucial informative knowledge to provide effective improved treatments and 
vaccination strategies against particular Leishmania spp. and potentially other intracellular 
pathogen that cause chronic disease by indicating the importance of inducing a protective 
antibody response. 
2. Material and Methods: 
1.1 2.1 Mice 
C3HeB/FeJ (C3H) and C3Smn.CB17-Prkda^/J (C3H scid) mice were obtained from 
Jackson Laboratory (Bar Harbor, Maine). The mice were maintained in a specific-pathogen-
free facility. Mice were infected with 5xl06 stationary-phase promastigotes in 50 pi\ of PBS 
in the left hind footpad. All procedures involving animals were approved by the Committee 
on Animal Care at Iowa State University. 
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2.2 Parasites 
Leishmania major (MHOM/IL/80/Freidlin) and Leishmania amazonensis 
(MHOM/BR/OO/LTBOO16) promastigotes were grown to stationary phase in Grace's insect 
culture medium (Technologies, Gaithersburg, MD) with 20% heat-inactivated PCS, 2 mM 
glutamine, 100 U penicillin per ml, and 100 fig of streptomycin per ml. Amastigotes used for 
infection were tissue derived and were harvested from lesions of C3H SCID mice as 
previously described (15). Freeze-thawed Leishmania antigen (Ag) was obtained from 
stationary-phase promastigotes as described (16). 
2.3 Cells and cell culture 
Cells were obtained from bone marrow (15-20 x 106 cells) and plated in a 150 x 15 
mm Petri dish with 30 ml of macrophage medium containing 30% L-cell conditioned 
medium, 20% FCS and 50% Dulbecco's modification of eagle's medium (DMEM), 2 mM 
glutamine, 100 U penicillin per ml, 100 jig of streptomycin per ml, and 1 mM sodium 
pyruvate at 37 °C and 5% C02. After 2 days another 20 ml of macrophage medium was 
added. At day 6 the non-adherent cells were washed and adherent cell populations were 
harvested by placing the plates on ice for 20 min and then scraping with a tissue scraper. 
After washing in PBS, the live cells were counted using trypan blue exclusion and 
resuspended in complete tissue culture medium (CTCM) containing DMEM, 10% FCS, 2 
mM glutamine, 100 U penicillin per ml, 100 fig of streptomycin per ml, 25 mM 4(2-
Hydroxyethyl)piperazine-1 -ethane sulfonic acid (HEPES), and 0.05 fiM 2-0-
mercaptoethanol. 
80 
Lymph node cells were obtained from the LN draining infection site (left hind foot) 
of animals infected for 4 weeks with either L. amazonensis or L. major. The poplitial, 
inguinal and prescapular LN were collected from non-infected mice. LN from 4-10 mice 
were pooled in 2 ml CTCM and the cells separated with a 2 ml tissue grinder, then washed 
with 10 ml CTCM at 300xg, 4 °C for 10 min. LN cells were re-suspended in 4 ml CTCM and 
passed through 40 fxm nylon cell strainer (BD Falcon, Bedford, MA). Lymph nodes cells 
were counted using trypan blue exclusion. 
2.4 Lymph node cell sorting 
CD4+ T cells, B cells, CD8+ T cells, MHCIP cells, and CD1 lb+ were depleted by 
incubating the cells first for 5 min at room temperature with one of the following primary 
antibodies per 1x10s lymph node cells; Rat anti-mouse CD4 (15p,g), CD19 (25pig), CD8a 
(lO^g), MHCII (I-A\ 25 ng) or CD lib (12 |xg) (LEAF, Biolegend, San Diego, CA), then 
washed. Cells were incubated for 15 min at 4 °C with the goat anti-rat IgG Microbeads 
(Miltenyi Biotec, Aburn, CA) according to manufacturer directions. A kit for negative 
selection of CD4+ T cells (Miltenyi Biotec, Auburn, CA) and B cells (MagCellect, R&D 
system, Minneapolis, MN) were used as directed by manufacturers. Cells were then 
separated using an autoMACS™ separator (Miltenyi Biotec, Auburn, CA). After washing the 
sorted cells with PBS once, they were re-suspended in 1 ml CTCM and counted using trypan 
blue exclusion. Cell purity was assessed using FACS analysis (see Fig A 4,5 and 6). 
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2.5 Macrophage infection and cell co-culture 
BMM were plated in 24 well plates with glass coverslips at a rate of 5x10s cells/well, 
in 1 ml CTCM. After 24 h the BMM were infected with either L. major or L. amazonensis 
amastigotes at a 3:1 ratio and incubated at 34°C for 24 h. The wells were washed two times 
with DMEM to remove extracellular amastigotes and 500 /d of CTCM was added. Lymph 
node cells were added with Ag (50 /<g/ml) and the volume was adjusted to 1 ml CTCM. 10 
fiM Mn(III)Tetrakis(4-benzoic acid) porphyrin chloride (MnTBAP, BIOMOL, Plymouth 
Meeting, PA) were added at the time of LN cell addition as indicated. The coverslips were 
removed after 5 days incubation at 34 °C with 5% C02, and stained using nonspecific HEMA 
3 stain set (Fisher Diagnostics, Middletown, VA) and mounted on glass slides. 
2.6 Determination of the infection rate of macrophages and parasite count 
Coverslips were counted under the light microscope by examining 3 areas at lOOOx 
total magnification. In each area, 100 macrophages were examined and the number of 
infected macrophages and the number of parasites in each macrophage were counted. The 
average of the 3 areas was used to determine the percent of infected macrophages and the 
number parasites per macrophage on each coverslip. 
2.7 Antibody Coating beads 
Polystyrene beads (Interfacial Dynamic Co., Tualatin, OR) were washed 2 times with 
2 ml sterile PBS in 5 ml tube and centrifuged at 453g for 10 min at 4 °C. The beads were 
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then counted using a hemocytometer and resuspended in 500 fxl PBS. A specific number of 
beads was incubated with the antibodies; goat anti-mouse IgG/IgM or goat anti-rat IgG 
(Jackson ImmunoReasearch Laboratories, West Grove, Pa) at a concentration of 12.5 pg/ml 
at 4 °C with shaking, overnight. Beads were washed 2 times with CTCM and centrifuged at 
453xg fro 10 min at 4 °C then resuspended in 1 ml CTCM and incubated at room 
temperature for 1 h. Beads were stored at 4 °C until use. Beads were added at 15xl06beads/ 
well. 
2.8 Western blot 
The supemates of the cultures either without beads, with goat anti-mouse IgG/IgM 
or goat anti-rat IgG coated beads were used to measure antibody levels. 300 pi of the 
supernatant from these cultures was mixed with 30 pi Protein A Agarose beads and 
incubated overnight at 4 °C on the shaker. The tubes were centrifuged at 13000xg for 1 min, 
the supernatant was removed, the beads were washed once with PBS, and resuspended in 25 
jaI lysis buffer (0.32 M sucrose, 3 mM calcium chloride, 2 mM magnesium acetate, 0.1 mM 
EDTA, 10 mM Tris(Hydroxyethyl) aminomethane (Tris) (pH 8.0), 5 mM sodium fluoride, 1 
mM dithiothritol (DTT), 0.5 mM phenylmethanesulfonyl fluoride (PMSF), 0.1 mM sodium 
orthovanadate and 1% nonidet P-40). 5 pi of 6x loading buffer was added and the mixture 
was heated at 95 °C for 4 min. Samples were separated using 8% PAGE and transferred to a 
nitrocellulose membrane using a semi-dry blotting apparatus (Bio-Rad, Hercules, CA). The 
membrane was blocked with 5% nonfat dry milk in PBS 0.1% Tween. Peroxidase-
conjugated goat anti-mouse IgG (H+L) (Jackson ImmunoResearch, West Grove, PA) was 
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hybridized to the membrane overnight at 4 °C at a 1:25000 dilution. Bound peroxidase 
conjugated antibody was detected using Pierce Supersignal Reagents (Pierce, Rockford, IL) 
as directed by the manufacturer. 
2.9 Determination of nitric oxide and IFN-y 
Nitrite concentrations were determined using the Greiss reagent as described 
previously (17). Briefly, equal volumes (50 pà) of cell culture medium and Greiss reagent 
(LabChem, Pittsburgh, PA) were mixed and incubated at room temperature and the 
absorbance was measured at 550 nm with a microplate reader (Molecular Devices, 
Sunnyvale, CA). The nitrite concentration was determined using a standard curve generated 
with sodium nitrite. Levels of IFN-y protein were determined by ELISA with commercially 
available antibodies (Pharmingen, San Diego, Ca), peroxidase-conjugated streptavidin 
(Jackson ImmunoResearch Laboratories, West Grove, Pa.) and ABTS microwell peroxidase 
substrate (Kirkegaard & Perry Laboratories, Gaithersburg, Md.) according to manufacturer 
recommendations 
2.10 Statistical analysis 
Data analysis was performed by using Statview 5.0.1 (SAS, Cary, NC). Statistical 
significance (set at p<0.05) was determined paired using t-test as indicated. 
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Results 
Total lymph node cells from mice infected with L. major can induce BMM to kill L. 
amazonensis amastigotes in vitro via L. major specific antigen. 
Previous in vivo studies from our laboratory show that re-challenging healed L. major 
infected mice with L. amazonensis 11-15 weeks post-infection leads to resolution of their L. 
amazonensis infection (9). Here we test the hypothesis that LN cells draining the infection 
site of L. major infected mice can activate in vitro BMM infected with L. amazonensis to 
control infection. Mice were infected in the footpad with either L. amazonensis or L. major 
promastigotes for 4 weeks, the time by which the lesion in mice infected with L. major was 
starting to heal. The draining LNs were removed, pooled and disaggregated into single cell 
suspension. LN cells were placed in culture with BMM macrophages previously infected for 
24 hrs with either L. amazonensis or L. major amastigotes. The co-cultures were then 
incubated with parasite Ag corresponding to the primary in vivo infection, for example LN 
cells derived from L. major infected mice were stimulated with L. major antigen and 
incubated for 5 days at 34 °C. Total lymph nodes cells from L. major infected mice caused a 
significant reduction in both the percent of macrophages infected and the number of parasites 
per macrophage in L. amazonensis infected BMM compared to LN cells from L. 
amazonensis infected mice (Fig. la). This reduction was antigen dependent (data not shown 
and Fig. 2). As seen in Figure lc, vacuoles in the L. amazonensis infected macrophages were 
smaller and fewer parasites per macrophage were seen after adding LN cells from L. major 
infected mice compared to adding LN cells from L. amazonensis infected mice (Fig. lb). 
These findings indicate that stimulated immune cells from L. major infection can induce 
BMM infected with L. amazonensis to reduce an in vitro infection. 
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L. amazonensis Ag failed to induce L. major LN cells to activate BMM to reduce L. 
amazonensis infection, reduction in infection rate is the reduction in the percent infected 
BBM compared to percent infected BMM after the addition of LN cells from L. amazonensis 
mice (Fig 2a), implicating a specific requirement for L. major Ag to stimulate L. major 
lymph node cells and produce killing in L. amazonensis infected BMM. However, after L. 
amazonensis Ag was added, L. major LN cells induced a reduction in the percent of L. major 
infected macrophages (Fig 2b), indicating that L. amazonensis Ag does not inhibit either 
BMM activation or DLN cells response. 
To confirm this specificity of L. major LN cells for L. major Ag, LN cells from non-
infected (C3H) mice were co-cultured with L. amazonensis infected BMM and to either L. 
amazonensis Ag, L. major Ag or no Ag (Fig 2c). These naïve LN cells were not able to 
induce activation of macrophages regardless of Ag source (Fig. 2c). Therefore, the response 
that controls L. amazonensis infection in BMM is specific to DLN cells derived from L. 
major infected mice and restimulation with L. major Ag. 
CD4* T cells are necessary, but not sufficient to induce BMM to control L. amazonensis 
infection. 
The population of total lymph node cells includes multiple cell types that may 
participate in macrophage activation. The importance of CD4+ T cells in vivo in controlling 
Leishmania infection has been well characterized (reviewed in (18)). To test whether CD4+ T 
cells are necessary and sufficient alone to induce BMM activation in our system, we either 
depleted CD4+ T cells from the DLN cell population by positive selection or negatively 
selected CD4+ T cells to use in the in vitro assay. The results in figure 3a clearly demonstrate 
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that CD4+ T cells are necessary for BMM activation and L. amazonensis killing. In contrast, 
co-culture of CD4+ T cells alone with L. amazonensis infected macrophages was not 
sufficient to induce killing of the parasite (Fig. 3a). These results suggested other cells, in 
addition to CD4+ T cells, are necessary to reduce BMM infection. Other cell types thought to 
participate in controlling intracellular parasite infection include; CD8+ T cells, CD1 lb+ 
(macrophages and dendritic cells) and/ or MHCII positive cells (macrophages, DC, and B 
cells). Depletion of CD8+ T cells did not have a significant effect on ability of macrophages 
to the kill L. amazonensis parasites while limited significant effect was seen with CD1 lb+ 
cells depletion (Fig 3b). The combination of CD4+ T cells and CD8+T cells also did not 
induce macrophages to induce reduction in L. amazonensis infection (data not shown). 
However, depletion of MHCII positive cells did significantly reduce parasite killing with 
almost completely abrogating the effectiveness of the DLN cells (Fig. 3b). Therefore, a long 
with CD4+ T cells, a population of MHCIIVCDl lb cells are critical to effectively activate L. 
amazonensis infected macrophages to kill intracellular L. amazonensis. 
B cells and CD4+ T from draining lymph nodes of L. major infected mice, together, are 
sufficient to control L. amazonensis infection. 
The MHCIIVCDl lb" cell type of highest abundance are B cells. To test whether B 
cells play a role in macrophage activation to kill intracellular L. amazonensis, the DLN cells 
were depleted of B cells and then co-cultured with L. amazonensis infected BMM as 
previously described. Removal of B cells by positive selection using an anti-mouse CD 19 
antibody abrogated the ability of DLN cells to activate macrophages to kill L. amazonensis 
parasites (Fig. 4a). Addition of negatively selected B cells, tested as CD19+ cells, as 
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described in the material and methods to L. amazonensis infected macrophages was not 
sufficient to control infection (Fig. 4a). However, combining B cells and CD4+ T cells 
isolated from draining lymph nodes cells of L. major infected mice was sufficient to activate 
macrophages and recover the majority of parasite killing characteristic of the total DLN cell 
population (Fig 4a). Mixing B cells from L. major infected mice with CD4+ T cells from L. 
amazonensis infected mice or mixing CD4+ T cells from L. major infected mice with B cells 
from L. amazonensis infected mice did not induce a reduction in L. amazonensis infection 
(Fig. 4b). These results indicates that both the CD4+ T cells and B cells must be from mice 
infected with L. major (Fig. 4b), suggesting that both CD4+ T cell and B cells from L. 
amazonensis infected mice are deficient in critical effectors molecules which stimulate 
infected macrophages to kill L. amazonensis parasites. 
Soluble factors are responsible for controlling L. amazonensis infection in BMM. 
To define the mechanism by which lymph nodes cells activate infected macrophages, 
we studied whether direct contact between the LN cells and macrophages is necessary. 
Therefore we used total DLN cells or purified CD4+ T cells and B cells in a transwell system 
as described in the material and methods. We found that effective macrophage activation was 
not dependent upon direct contact (Fig 5a), although CD4+ T cells did require interaction 
with a MHCIT cells via direct contact with either the macrophage or B cells (Fig. 5a). 
The requirement for a soluble factor from B cells suggested a role for antibody in this 
in vitro system. To test this, goat anti-mouse IgG-IgM coated polystyrene beads were used in 
the transwell system with total LN cells draining L. major infected mice and goat anti-rat IgG 
coated beads were used as a control. Inclusion of the anti-mouse IgG/TgM coated beads 
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significantly reduced the ability of DLN cells to promote killing of intracellular L. 
amazonensis amastigotes (Fig 5b). Antibody reduction did not play a significant role in the 
control of L. major infection in BMM (Fig. 5b). Supemates from these cultures were 
analyzed via western blot with anti-mouse IgG to confirm a reduction of IgG in bead added 
cultures. IgG levels were significantly reduced in supemates of co-culture with anti-IgG 
coated beads as compared to the supemates of total LN cells, without beads (Fig 5c and d). 
These studies show that control of L. amazonensis infection, but not L. major infection, by L. 
major LN cells in the infected BMM co-culture assay is antibody dependent. 
Lymph node cells from L. major infected mice induce the control ofL. amazonensis 
infection through a superoxide dependent pathway. 
IFN-y is the main Thl cytokine produced from CD4+ T cells and a potent macrophage 
activator. However, no correlation was found between the ability of the macrophage to 
induce parasite killing and IFN-y production in the co-culture system (R2= 0.045) (Fig 6a). 
Nitrite levels were also measured in the supemates, as a reflection of nitric oxide levels 
which is a common measure of macrophage activation. No direct correlation was found 
between the infection rate and nitrite levels (R2= 0.0046) (Fig 6b). These results do not 
exclude the importance of IFN-y and NO in this system, but it suggests that there are other 
factors in our in vitro system which may significantly enhance the ability of activated 
macrophages to kill L. amazonensis amastigotes. 
A previous study using liposomal-IgG to ligate Fc receptors on L. donovani infected 
macrophages, showed that this ligation initiated control of infection through superoxide and 
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hydrogen peroxide production (14). We hypothesized that antibodies produced by B cells 
within the population of LN cells from L. major-infected mice may stimulate macrophages 
through a superoxide dependent pathway to promote parasite killing. Addition of a cell 
permeable superoxide dismutase mimic (MnTBAP) to cultures abrogated the killing almost 
completely, while although the L. major infection rate was affected, it was inhibited to a 
much lesser extent (35.01 to 20.62%) (Fig. 6c). Killing of L. amazonensis is therefore 
dependent on superoxide production. In conclusion, these results suggest that CD4+ T cells 
and B cells from DLN cells of L. major infected mice induce intracellular L. amazonensis 
killing, and secreted factors including antibodies induce this killing through a superoxide 
dependent mechanism. 
Discussion 
This work reports for the first time the ability of draining lymph node cells from L. 
major infected C3H mice to activate BMM and reduce the L. amazonensis amastigotes 
infection rate in vitro (Fig. 1). Also proposes a mechanism by which this reduction occurs. 
These findings are supported by previous in vivo data from our lab in which healed L. major 
infected mice were able to cure a secondary L. amazonensis infection (9). The immune 
response from L. major infected mice that induced L. amazonensis killing is specific for L. 
major Ag and notZ. amazonensis Ag (Fig. 2a). L. major antigen alone could not induce 
activation of lymph nodes cells obtained from naïve or L. amazonensis infected mice (Fig 2 b 
and c), indicating it is not the activity of the L. major Ag, but the specificity of the immune 
response and lymphocytes to L. major Ag that induces the activation in the macrophages. 
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Previous in vivo studies have shown the importance of CD4+ T cells in promoting 
healing of Leishmania infection (reviewed (18)). The necessity for CD4+ T cells in our co-
culture system (Fig. 2) is consistent with this understanding of the anti-Leishmania immune 
response. Despite this, it has been previously reported that removal of CD4+ T cells leads to 
diminished pathology and decreased parasite counts after L. amazonensis infection in 
C57BL/6 mice, indicating a role for CD4+ T cells in the pathogenesis of this parasite (19). In 
our system, CD4+ T cells are necessary for the reduction in the infection rate, but they are 
alone not sufficient to induce this reduction (Fig. 3a). Unexpectedly, the additional required 
cell type was not CD8+ T cells or dendritic cells (Fig 3b). To date, the literature varies in its 
determination for the role of CD8+ T cells in clearing Leishmania infection, results differ 
based on the parasite dose or species and vaccine strategy (20,21, 22). A role for CD8+ T 
cells in producing IFN-y to augment CD4+ T cell responses also has been shown (23,24). In 
our system, CD8+ T cells were not found to be necessary (Fig. 3b) and neither dendritic cells 
(DCs) nor macrophages, both of which express CD1 lb, play a major role in our system 
(Fig3b). DCs do have a role in initiating the immune response and in presenting Ag to CD4+ 
T cells (25). 
The role of B cells in an effective immune response to Leishmania in murine model is 
controversial and may be dependent on the Leishmania species and/or strain of mice 
(reviewed in (1)). Many previous reports showed that either B cells are not necessary (26,27) 
or even that the immune response was enhanced in controlling infection in the absence of B 
cells (28,29). Only a single study done using C3H mice infected with L. major shows the 
necessity for B cells to generate a healing T cell response (30). In our experimental system, B 
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cells were found to be necessary but not sufficient alone to activate macrophages, but 
together with CD4+ T cells could activate the macrophages to kill L. amazonensis (Fig. 4a). 
The inability to substitute either CD4+ T cells or B cells with the same cell types 
isolated from LN of L. amazonensis infected mice (Fig 4b) might suggest not only a defect in 
CD4+ T cells from L amazonensis infected mice described previously (8,16,31,19), but also 
a defect in B cells from L. amazonensis infected mice, particularly in their ability to secret 
necessary factor(s) to induce the proper BMM activation for parasite killing. Part of this 
defect could be as a result of the poor CD4+ T cells response, which in turn may not induce 
an effective B cell response. Lower levels of IgG2a has been shown in the serum of L. 
amazonensis infected mice in vivo as compared to the serum from L. major infected mice 
(16). In our system, lower levels of total IgG and levels of IgG2a were detected in the culture 
of LN cells from L. amazonensis infected mice compared to LN cells from L. major infected 
mice (Figure A 3). This is not only an indication of a poor Thl response, but may be also 
reflect a defect in B cells is induced by L. amazonensis infection. 
Lemos, (32) showed macrophage MHCII/ CD4+ T cells contact is not necessary for 
macrophage activation. In figure 4a, a transwell system ruled out the necessity of direct 
contact for BMM activation in our co-culture system. This result does not exclude the need 
for contact between CD4+ T cells and MHCII bearing cells in vivo to promote T cell 
activation. Instead it signifies that in this system B cells are not acting only as APC for CD4+ 
T cells, but instead suggests that secreted factors) produced from B cells participate in the 
control of L. amazonensis infection. These findings indicate that there are critical elements 
produced by B cells which promote macrophage killing of these intracellular parasite. 
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The role of antibodies in Leishmania infection is as controversial as the role of B 
cells. Antibodies have been shown to play a role in the resistance of opsonized parasite to 
macrophage activation by inducing IL-10 production (11). Antibody is also crucial to L. 
mexicana entry into macrophages via the Fc receptors binding and sustenance of the 
infection (10). Conversely, antibodies were reported to induce the control of Leishmania 
infection in vitro (14) and in vivo (33). In our system the antibodies were necessary to induce 
macrophages to kill L. amazonensis. After addition of antibody depleting beads to the co-
culture, a low level of antibody was still detected (Fig 5d). The incomplete abrogation of 
killing could be due to this remnant level of antibodies in the culture (Fig 5b). 
Recently, we have shown NO production was sufficient for BMM infected with L. 
major amastigotes to control infection, while control of L. amazonensis infection requires 
both NO and superoxide production (Mukbel, et al., 2005, submitted). Control of L. major 
infection in our in vitro assay was not affected by a reduction of antibody levels in the 
culture (Fig 5b), supporting our previous finding that superoxide is not required to control L. 
major infection. Inhibition of superoxide using MnTBAP induced a minimal effect in 
parasite reduction during L. major infection, while a dramatic abrogation of L. amazonensis 
killing was seen (Fig 6c). No correlation was found with either IFNy or NO and the ability of 
macrophages to control L. amazonensis infection (Fig 5 a and b). IFNy itself was shown to 
enhance L. amazonensis replication (7) which might explain the absent of direct correlation 
between IFN-y and killing of L. amazonensis amastigotes. 
In conclusion both B cells and CD4+ T cells from DLN cells of L. major infected 
mice are necessary to activate macrophages to kill intracellular L. amazonensis amastigotes 
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within. This response is antigen dependent and requires secreted factors produced from the 
two cells types including antibodies from B cells. These secreted factors induced L. 
amazonensis killing in a manner utilizing superoxide production. This link, indicated by the 
involvement of both CD4+ T cells and B cells in our system, between humoral and cell-
mediated immunity may be critical for vaccine development against Leishmania. 
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Figure 1. DLN cells isolated from mice infected for 4 week with L. major induce BMM to 
reduce L. amazonensis infection as compared to DLN cells isolated from L. amazonensis 
infected mice. C3H mice were infected with 5x10* L. major or L. amazonensis promastigotes 
in the left footpad. 4 weeks post-infection the DLN were removed and 5xl06 total cells were 
added on top of 5x10s BMM previously infected with 1.5x10* L. amazonensis amastigotes as 
described in material and methods. Antigen (50/ig/ml), L. amazonensis Ag or L. major Ag to 
cultures with LN cells from mice infected with L. amazonensis or L. major, respectively, was 
added and the cells were incubated for 5 days at 34 °C. A) Percent infected macrophages and 
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number of parasites per infected macrophage was calculated as described in the materials and 
methods. The results are the average of 8 experiments + standard error. Figure b) Image of 
BMM macrophages infected with L. amazonensis after the addition of LN cells from L. 
amazonensis infected mice. C) Macrophages the same as b with LN cells from L. major 
infected mice. 
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Figure 2. Both DLN cells from L. major infected mice and L. major derived antigen are 
needed to induce a reduction in infection rate of L. amazonensis infected mice. LN cells were 
obtained as described in figure 1. a) L. amazonensis infected BMM were co-incubated with 
LN cells from L. major infected mice (L. major LN) and either L. major or L. amazonensis 
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antigen (L. major Ag or L. amaz. Ag), or L. amazonensis LN cells (L. amaz. Ag) with L. 
major antigen. Reduction in % infected macrophages= (1- (% infected macrophages with LN 
cells from L. major infected mice / % infected macrophages with LN from L. amazonensis 
infected mice))* 100. b) L. major infected macrophages were incubated with LN cells from 
L. major infected mice and either L. major antigen or L. amazonensis antigen, c) L. 
amazonensis infected BMM were incubated with LN node cells from non-infected mice with 
no antigen, L. amazonensis antigen, or L. major antigen. Results are an average of 3 
experiments ±_S.E. (*) infection rate is higher than the control i.e. infection rate of 
experimental groups was higher than the infection rate of L. amazonensis infected 
macrophage with LN cells from L. amazonensis infected mice). 
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Figure 3. Both CD4+ T cells and MHCII7CD1 lb" cell types are necessary to induce BMM to 
reduce L. amazonensis infection rate. DLN cells of L. major infected mice, were harvested as 
described in the figure 1. a) CD4+ T cells were depleted from DLN cell population by 
positive selection or CD4+ T cells were enriched by negative selection as described in the 
material and methods and used in the co-culture with L. amazonensis infected BMM as 
described in figure 1. The results are average of 5 experiments +S.E. b). MHCII, CD8 or 
CD1 lb positive cells were depleted from the DLN cells of L. major infected mice as 
described in the materials and methods and co-cultured with L. amazonensis BMM as in fig 
3a. The results are average of 3 experiments with ± S.E. 
*= Statistically significant from the Total DLN cells 
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Figure 4. L. major-specific B cells and CD4+ T cells together are necessary to control L. 
amazonensis infection in vitro. LN cells from L. major infected mice were isolated as 
described in Figure 1. BMM infected with L. amazonensis amastigotes as in figure 1. a. Total 
LN cells (Total), B cell depleted (CD 19* cell depletion), B cells alone (B cell enrichment), or 
B cells and CD4+ T cells (B cells and CD4) were isolated as described in the material and 
methods. The results are the average of 3-4 experiments +S.E. b. B cells and CD4+ T cells 
were sorted from LN cells of mice infected either with L. amazonensis or L. major (B cells 
Lamazo. or L. major, CD4+ T cells L. amazo. or L. major) and added to L. amazonensis 
infected BMM. Results represent an average of 2-3 experiments +S.E. (*) infection rate was 
actually higher than the control as described in figure 2. 
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Figure 5. Secreted factors from B cells and CD4+ T cells are sufficient to reduce the infection 
rate of L. amazonensis infected BMM. DLN cells from L. major infected mice were used 
sorted and added as described in figure 4. a) Either total LN cells (Total LN) or negatively 
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sorted B cells and CD4+ T cells were added to the upper chamber or lower chamber (lower) 
as indicated in transwell with L. amazonensis infected BMM in the lower chamber, killing 
was determined as in figure 1. Results are the mean ± of 3 independent experiments, b) Total 
LN cells from L, major infected mice were added into the upper chamber of transwell as in a. 
either alone or with goat anti-mouse IgG/IgM coated beads to macrophages infected with 
either L. amazonensis or L. major as indicated, c) A representative image of an immuno-blot 
using goat anti-mouse IgG Protein A precipitated supemates of co-cultures separated with 
PAGE as described in the material and methods to detect levels of IgG in the transwell with 
or without the beads, d) An average of densitometry results of three experiments +S.E., (*) 
p<0.05. 
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Figure 6. Reduction in the infection rate of BMM infected with L. amazonensis is superoxide 
dependent. The supemates of the cell cultures of L. amazonensis infected BMM with DLN 
cells types were used to quantified the amount of (a) IFNy and (b) nitrite and plotted against 
infection rate of the co-infection, (c). total LN cells from L. major infected mice were 
obtained as described in figure 1 and added to BMM infected with either L.amazonensis or L. 
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major amastigotes, with or with out 10 piM MnTBAP and incubated in the presence of 
antigen for 5 days. These results are the average of 3 experiments ± S.E. in duplicate. (*) p< 
0.05 compared to no MnTPAB treatment. 
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CHAPTER 4 
Leishmania infection modulates the expression of Fey receptors 
Paper prepared to be submitted to Infection and Immunity 
Rami M. Mukbel and Douglas E. Jones 
Abstract: 
Antibody and Fc receptors were recently been shown to act as virulence factors for 
Leishmania infection susceptible mice. These host molecules are co-opted by the parasite to 
play a role in pathogenesis of Leishmania infection either as a mode of entry into the cell, 
triggering IL-10 production, or both. Recently, we demonstrated an antibody-mediated 
mechanism of macrophage activation utilized by draining lymph node cells isolated from 
Leishmania major infected mice which promotes killing of intracellular!,, amazonensis 
amastigotes. In this previous work it was demonstrated that soluble factors from B cell and 
CD4+ T cells isolated from lymph node (LN) cells of L. major infected animals were able to 
promote macrophage killing of L. amazonensis amastigotes, that parasite killing was 
antibody mediated. In this work, using immune serum from mice chronically infected with L. 
major, we could not promote parasite killing. To further explore these findings, we wanted to 
measure FcyR expression on infected macrophages to test the hypothesis that these activation 
receptors may be differentially regulated by infection with L. amazonensis vs L. major. 24 
hour post-infection with either L. major or L. amazonensis amastigotes, CD64 (FcyRI) and 
CD32 (FcyRII) expression was measured using RT-PCR. Both parasites induced down-
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regulation of CD64 and up-regulation of CD32 expression in infected BMM. While addition 
of LN cells from either L. amazonensis infected mice or L. major infected mice had similar 
effects on macrophages CD64 expression, LN cells from L. major infected mice induced a 
downregulation of CD32 expression on BMM compared to LN cells from L. amazonensis 
infected mice. In conclusion, this is the first report to show that both infection with 
Leishmania spp. and addition of LN node cells from Leishmanfa-infected mice can 
differentially modulate expression of Fey receptors in BMM. 
Introduction 
Leishmania, an obligatory intracellular parasite, establishes infection within vacuoles 
of host macrophages. For these parasites to survive, they need to escape host lysis factors, eg. 
complement, during invasion and resist further intracellular macrophage killing mechanisms. 
Leishmania was shown to enter macrophages by phagocytosis through different receptors 
dependent on parasite developmental stage and species. These receptors include complement 
receptors, Fc receptors and the mannose receptor (reviewed in (20)). Fc receptors are a group 
of macrophage surface receptors, also found on other cell types including B cells, which have 
been shown to be used by antibody opsonized Leishmania for macrophage invasion (14,4) 
and evasion of macrophage activation (13,15,2,17). 
Fc receptors are responsible for recognition of the Fc portion of antibodies. Specific 
Fc receptors recognize a particular antibody class and isotype with different affinities and 
avidities (11). Aggregation of these receptors after binding antibody triggers phagocytosis of 
antibody-bound antigen, including antibody opsonized Leishmania (8). Receptor aggregation 
can also induce modulation of macrophage function the characteristic of which are 
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determined by the type of antibodies associated with antigen and the receptors subtype 
present on the macrophages. For example CD64, FcyRI, can induce macrophage activation 
through a cytoplasmic ITAM motif of the receptor after binding to IgG2a with high affinity, 
while CD32, FcyRIIb, has an inhibitory IUM motifs which binds to IgGl antibody isotype 
and inhibits macrophage activation, but still can promote antibody bound antigen 
phagocytosis (5,18). To date, the role of Fc receptors in immunity to Leishmania infection 
has mostly been studied via genetically modified knockout mice and the direct effect of 
infection on expression of these receptors has not yet been determined. 
The varying macrophage responses which depend on antibody subtype and 
particularly Fey receptor expression may explain the result that although antibody has been 
shown to play a role in limiting the immune response to L. major other studies indicate a role 
for antibodies in promoting macrophage activation and killing of Leishmania, Monoclonal 
antibody raised against Leishmania spp. was shown to induce protection in vitro against L. 
major promastigotes and in vivo against both L. amazonensis and L. major parasites (1,7). 
Activation of Leishmania infected macrophages with IgG to ligate Fc receptors results in 
superoxide and hydrogen peroxide production and in the presence of IFN-y, nitric oxide is 
produced (6). 
In this work we extend previous studies in our laboratory showing that LN cells from 
L. major infected mice can reduce the infection rate of BMM infected with L. amazonensis 
amastigotes and that this reduction was dependent on antigen specific CD4+ T cells, B cells 
and IgG. Here we examined whether immune serum could replace B cells and together with 
antigen responsive CD4+ T cells from L. major infected mice induce macrophage activation 
I l l  
to kill intracellular L. amazonensis infection. In this work, immune-serum from healed L. 
major infected mice did not promote a reduction in the infection rate in L. amazonensis 
infected BMM. While macrophage infection with either L. amazonensis or L. major induced 
reduction in CD64 mRNA expression compared to non-infected BMM, CD32 mRNA 
expression was upregulated. However, LN cells from L. major infected mice induced a 
reduction in CD32 expression. These findings suggest a role for Leishmania infection and 
host LN cells in modulation of Fc receptor expression in BMM which could influence 
productivity of host response. 
2. Material and Methods: 
Mice 
C3HeB/FeJ (C3H) and C3Smn.CB 17-Prkda**Vj (C3H scid) mice were obtained from 
Jackson Laboratory (Bar Harbor, Maine). The mice were maintained in a specific-pathogen-
free facility. Mice either used for the lymph nodes experiments, serum, or propagation of 
lesion derived amastigotes (C3H SCID) were infected with 5x 106 stationary-phase 
promastigotes in 50 jil of PBS in the left hind footpad. All procedures involving animals 
were approved by the Committee on Animal Care at Iowa State University. 
Parasites 
Leishmania major (MHOM/IL/80/Freidlin) and Leishmania amazonensis 
(MHOM/BR/OO/LTBOO16) promastigotes were grown to stationary phase in Grace's insect 
culture medium (Technologies, Gaithersburg, MD) with 20% heat-inactivated FCS, 2 mM 
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glutamine, 100 U penicillin per ml, and 100 fig of streptomycin per ml. Amastigotes used for 
infection were tissue derived and harvested from lesions of C3H SCID mice as described 
(19). Freeze-thawed Leishmania antigen (Ag) was obtained from stationary-phase 
promastigotes as described in (12). 
Cells and cell culture 
Cells were obtained from bone marrow of the femur and tibia (15-20 x 106 cells) and 
plated in a 150 x 15 mm Petri dish with 30 ml of macrophage medium containing 30% L-cell 
conditioned medium, 20% PCS and 50% Dulbecco's modification of Eagle's medium 
(DMEM), 2 mM glutamine, 100 U penicillin per ml, 100 fig of streptomycin per ml and 1 
mM sodium pyruvate at 37 °C and 4% C02. After 2 days another 20 ml of macrophage 
medium was added to each dish. At day 6 non-adherent cells were removed by washing the 
plate two times with PBS and then placing the plates on ice for 20 min and scraping off the 
remaining adherent cell population. Live cells were counted using trypan blue exclusion and 
resuspended in complete tissue culture medium (CTCM) containing DMEM, 10% PCS, 2 
mM glutamine, 100 U penicillin per ml, 100 y.g of streptomycin per ml, 25 mM 4(2-
Hydroxyethyl)piperazine-1 -ethane sulfonic acid (HEPES), and 0.05 /iM 2-|3-
mercaptoethanol. 
Lymph node cells were obtained from LN draining mice infected for 4 weeks with 
either L. amazonensis and L. major. Poplitial, inguinal and prescapular lymph nodes were 
collected fro non-infected mice. LN from 4-10 mice were pooled in 2 ml CTCM and grinded 
with 2 ml tissue grinder and washed with 10 ml CTCM at 300 G, 4 °C for 10 min. LN cells 
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were re-suspended in 4 ml CTCM and passed through 40 p,m nylon cell strainer (BD Falcon, 
Bedford, MA). Lymph nodes cells were counted using trypan blue exclusion. 
2.4 Serum 
Blood was collected from C3H mice infected with L. major for 12 weeks. Serum was 
collected by incubating the blood at 4 °C overnight then centrifugating at 450xg for 10 min. 
Serum stored at 4 °C until used. 
Macrophage infection and cells addition. 
BMM were plated in 24-well plates with glass cover-slips at a rate of 5xl05 cells/well 
in 1 ml CTCM. After 24 h BMM were infected with either L. major or L. amazonensis 
amastigotes at a 3:1 ratio and incubated at 34°C for 24 h. Wells were washed two times with 
DMEM to remove extracellular amastigotes and 500 pil of CTCM was added. Lymph node 
cells were placed with Ag (50 pig/ml) either directly on BMM or in 0.4 pim in diameter 
transwell (Coming Costar, NY) to separate them from the macrophages (for RT-PCR 
experiments). Volume was adjusted to 800 pi in the wells and 150 pi in the transwell with 
CTCM. Antigen was added in the upper chamber with the LN cells. 15 pil serum with 50 pig 
Ag and 100U IFNy were added to indicated well with infected macrophages. This mix has 
incubated together for 5 days at 34 °C, 5% COz. 
Determination of the infection rate of macrophages and parasite count 
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Each individual coverslip was counted via light microscope by examining 3 areas at 
lOOx. In each area, 100 macrophages were examined and the number of infected 
macrophages and the number of parasites in each macrophage were counted. The average of 
the 3 areas was used to determine percent of infected macrophages and number of parasites 
per macrophage on each coverslip. 
RT-PCR. 
Either BMM macrophages infected for 24 hours or exposed to LN cells in the 
transwell system was used for total RNA extraction using Rapid Total RNA purification 
system (Marligen Biosciences, Ijamsville, Md.) according to the manufacturer's protocol. 
RNA concentration was measured spectrophotometrically; RNA samples were then treated 
with 1.5 U of DNase I (Pierce, Milwaukee, Wis.) per jag of RNA for 45 min at 37°C and 1 pg 
of each DNase I-treated RNA sample was reverse transcribed in 40-pl reaction volumes with 
IX Moloney murine leukemia virus reaction buffer (Promega), 100 U of Moloney murine 
leukemia virus reverse transcriptase (Promega), 20 U of RNase inhibitor (Applied 
Biosystems, Foster City, Calif.), 2.5 p.M random hexamers (Amersham Biosciences Corp., 
Piscataway, N.J.) and 0.5 mM each of the four deoxynucleoside triphosphates (USB 
Corporation, Cleveland, Ohio). RNA samples and random hexamers were incubated together 
at 70°C for 3 min and room temperature for 10 min. The reverse transcription reaction was 
performed at 42°C for 1 h; samples were then heated at 95 °C for 5 min and incubated on ice 
for 10 min. Real-time PCR experiments were run on the ABI Prism 5700 sequence detection 
system (Applied Biosystems, Foster City, Calif.). Each 25-jj.I reaction contained 0.5 pi of 
cDNA and IX ABsolute QPCR Mix (Abgene, Surrey, United Kingdom). 
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Forward and reverse primers were used at either 300 nM (IDT, Coralville, Iowa) and 
TaqMan probe for GAPDH labeled with the reporter dye 6-carboxyfluorescein and the 
quencher dye 6-carboxytetramethylrhodamine (Applied Biosystems, Foster City, Calif.) were 
used at either 75 or 100 nM. Primer pairs and probes were designed with Primer Express 1.5 
software (Applied Biosystems) and are listed in Table L For quantitative analysis of gene 
expression, normalized to an endogenous control, we used the standard curve method, which 
was detailed previously (10). Briefly, control cDNA samples were serially diluted to obtain 
standard curves for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) cDNA and each 
target cDNA. For each assay, the resultant cycle threshold (Ct) values were plotted against 
the input of RNA. For all experimental samples, the cDNA quantity for the target of interest 
was then determined from its standard curve and normalized to GAPDH control. 
Table 1. Sequences of primers and probe used for RT-PCR. 
Target GenBank Type Sequence (5' ^ 3') 
gene accession no. 
GAPDH M32599 F 
R 
P 
TGTGTCCGTCGTGGATCTGA 
CCTGCTTCACCACCTTCTTGA 
CCGCCTGGAGAAACCTGCCAAGTATG 
CD64 NM 010186 F CGAGCCAGACCACACCAAA 
R CTGCTCGGGTCCACAGTCA 
CD32 NM_010187 F 
R 
TCTTGCTGCTGGGACTCATG 
CCTTGAGCACCTGGATCCA 
Statistical analysis. 
The statistical significance between different treatments was calculated using student t-test. 
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Results 
Immune serum from L. major infected mice does not induce a reduction in infection rate o/L. 
amazonensis within macrophage. 
B cells and CD4+ T cells from L. major infected mice were found, together, (16) to be 
necessary to induce macrophage activation and reduce the rate of L. amazonensis infection 
within BMM. This reduction was at least in part antibody dependent. This triad of T cells/B 
cell and antibody has leaded us to question whether the immunoglobulin and IFNy alone are 
sufficient for macrophage activation. To test this hypothesis, immune serum from L. major 
infected mice for 12 weeks was added to L. amazonensis infected BMM either alone or with 
IFNy in the presence of antigen and incubated for 5 days. Serum with IFNy did not promote a 
reduction in the infection rate compared to total DLN cells from L. major infected mice (Fig. 
1). Even when immune serum was mixed with CD4+ T cells from L. major infected mice, 
still, no reduction in the infection rate was observed (Fig 1). These results indicate that 
additional B cells and CD4+ T cells derived immune factors, beyond immunoglobulin and 
IFNy, contribute to the effective macrophage response against L. amazonensis. 
Fey receptors are regulated by Leishmania infection 
We have previously demonstrated the necessity of immunoglobulin for macrophage 
activation during L. amazonensis infection in our in vitro system. The inability of immune 
serum to induce L. amazonensis killing made us question: 1) Do Leishmania amastigotes 
influence the expression levels of FcyR and 2) do the total LN cell population of L. 
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amazonensis or L. major-infected animals regulate FcyR expression levels of infected 
macrophages? After 24 h of parasite infection with either L. amazonensis or L. major 
amastigotes in BMM, mRNA expression of FcyRI (CD64) and FcyRII (CD32) were 
measured using real-time RT-PCR and compared to non-infected BMM. Both parasites 
reduced the expression of CD64 significantly compared to uninfected macrophages (Fig. 2a). 
In contrast, the infection with either Leishmania spp. induced an upregulation of CD32 
expression compared to uninfected macrophages (Fig 2b). No significant difference was 
detected in expression of either Fc receptor (CD64 and CD32) between L. amazonensis and 
L. major infection of BMM (Fig. 2 a and b). These results indicate that Leishmania 
amastigote infection modulatse BMM mRNA expression of Fey receptors. 
LN cells from Leishmania infected mice differentially modulated the expression of 
Fey receptors within infected BMM. 
The ability of the total LN cells to induce a reduction in infection rate in an antibody 
dependent manner, while the immune serum did not, suggested that LN cells from L. major 
infected animals may modulate Fc receptor expression to enable enhanced cellular response 
to antibody. To explore this, draining LN cells from mice infected for 4 weeks with either L. 
amazonensis or L. major were added alone with antigen in a transwell system separated from 
the macrophages infected with L. amazonensis amastigotes. After 5 days incubation, 
macrophages were analyzed for levels of mRNA expression of CD64 and CD32. No 
significant difference in the expression of CD64 was found between macrophages exposed to 
either L. amazonensis or L. major LN cells (Fig 3a), however macrophages exposed to LN 
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cells from L. major infected mice induced a significant reduction in mRNA expression of 
CD32 in comparison to L. amazonensis LN cells (Fig 3b). These results may indicate that LN 
cells from L. major infected mice secrete factor(s) which reduce expression of CD32. 
Discussion 
In this work we report for the first time the capability of Leishmania amastigotes to 
induce modulation of Fey receptor mRNA expression in BMM in vitro. DLN cells from L. 
major infected mice also induced downregulation of CD32 expression in L. amazonensis 
infected BMM. 
While lesion derived L. amazonensis or L. major amastigotes coated with antibody 
induced IL-10 production from macrophages (13), L. major promastigotes coated with 
Leishmania monoclonal antibodies produced by specific hybridoma cells were killed by 
macrophages after infection (9). These monoclonal antibodies protected mice from 
developing lesions in vivo when injected together with L. major or L. amazonensis 
promastigotes (7,1). Antibody and Fey have been shown to be necessary for parasites of L. 
mexicana complex to enter macrophages in vivo (14). Ligation of Fc receptors with IgG 
induced activation of macrophages to kill Leishmania via a PKC dependent pathway (6). 
These disparate findings demonstrate the differences in response to antibody with various 
Leishmania spp., which may be due to differences in both antibody and Fc receptor type 
involved in these various experimental systems. In our previous work with LN cells from L. 
major infected mice we demonstrated that activation of BMM and subsequent killing of L. 
amazonensis amastigotes was antibody dependent. In this current study, we could not recover 
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killing of L. amazonensis in BMM by adding either immune serum alone (data not shown) or 
immune serum with IFNy (Fig. 1). This suggested that there are other factor(s) produced 
from B cells and/or CD4+ T cells, in addition to antibody and IFN-y, that help inducing 
activation of macrophages to kill L. amazonensis. To begin to understand this phenomena 
and given the central role of antibodies in our experimental system, we hypothesize that both 
infection itself and DLN cells of L. major infected animals may influence the expression 
pattern of Fey receptors. 
Involvement of Fc receptor in resistance both Old World and New World species of 
Leishmania was demonstrated when susceptible strains of mice became resistant after 
deletion of Fc receptors (2, 15,17). Therefore the first time we show that Leishmania 
infection influences expression of these receptors in vitro. L. amazonensis was found to 
induce down-regulation of CD64 expression (Fc activation receptor) and upregulation of 
CD32 (Fc inhibitory receptor). This modulation of FcR is a technique utilized by other 
Kinatoplastidea as well; Trypanosoma cruzi has been shown also to upregulate expression of 
Fc receptors II/III (3). Addition of lymph nodes cells from either L. amazonensis or L. major 
infected mice did not promote a difference in the expression of CD64 (Fig 3a), which might 
suggest that both LN cell types can upregulate the expression of this receptor as either IL-10 
or IFN-y can also induce this upreglation (reviewed in (8)). In contrast, L. major LN cells 
significantly downregulate CD32 expression (Fig 3b) as compared to L. amazonensis LN 
cells. We propose that this downregulation may have a role in reducing the inhibitory signal 
to macrophages and allow macrophage activation through CD64 signaling producing 
superoxide needed to kill intracellular L. amazonensis the parasite. Factor(s) which induce 
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this downregulation has not been determined, but could be produced from either B cells or 
CD4+ T cells, or more likely a combination of both. 
We propose a model for the mechanism to activate macrophages to control L. 
amazonensis infection needs, both a proper balance in Fc receptors where CD64 expression 
is upregulated and CD32 expression is downregulated. At the same time specific antibody 
response, specifically IgG2a binds to CD64, induces activation of macrophages who then 
produce superoxide in the presence of nitric oxide and kill intracellular L. amazonensis. 
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Figure 1. Immune serum from L. major infected mice does not induce 
macrophage killing of L. amazonensis amastigotes. DLN cells from mice 
infected with L. major for 4 weeks (total LN cells), CD4+ T cells 
negatively sorted from these cells and/or serum from mice infected with L. 
major for 12 weeks with 100 U IFNy, were added to BMM infected with L. 
amazonensis amastigotes on cover slips with 50/tg/ml antigen and 
incubated for 5 days at 34 °C. Reduction % infected macrophage is equal 
to (1- %infected macrophages treatment / %infected macrophages with L. 
amazonensis LN cell)* 100. Error bars represent standard error. The data is 
an average of three separate experiments. 
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Figure 2. Leishmania infection modulates expression of Fey receptors. BMM 
were infected with either L. amazonensis or L. major or left uninfected. 
mRNA levels of A. CD64 and B. CD32 were measured using real-time RT-
PCR and adjusted to GAPDH levels as described in material and methods. 
Values are expressed as the ratio to target mRNA levels of uninfected 
macrophages. These data are averages ± SE of three separate experiments. 
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Figure 3 DLN cells from Leishmania infected mice modulate the 
expression of Fey receptors. DLN cells from C3H mice infected with either 
L. amazonensis or L. major for 4 weeks were added to in transwell system 
with Ag as described in materials and methods separated from BMM 
infected with L. amazonensis amastigotes and incubated for 5 days. The 
mRNA levels of a. CD64 and b. CD32 were measured using RT-PCR and 
adjusted to GAPDH levels. Values are expressed as relative to levels after 
the addition L. amazonensis LN cells. These data are averages ± SE of 
three separate experiments. 
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Chapter 5 
General conclusion 
The in vivo differential killing of L. amazonensis and L. major in C3H mice were 
reflected in vitro using BMM under identical activation conditions. We have shown that this 
delayed intracellular L. amazonensis killing when compared to L. major, occurred under 
conditions of similar levels of NO and iNOS. Even an exogenous source of NO (SNAP), that 
is sufficient to induce killing to intracellular L. major infection, did not have any affect on L. 
amazonensis intracellular survival. Other factors such as increased replication rate and IL-10, 
were not the major resistance factors of intracellular L. amazonensis to macrophage killing. 
Only when superoxide was induced in the presence of NO, was L. amazonensis killed in vitro 
to a similar level as L. major. This results indicates not only the host immune response to the 
two species of Leishmania is different, but also the requirements for their intracellular killing 
are different, as NO was sufficient alone for L. major intracellular killing, whereas L. 
amazonensis killing requires both NO and superoxide. 
Intracellular killing of L. amazonensis amastigotes inside macrophages was induced 
by the addition of DLN cells from L. major infected mice. This L. major antigen-specific 
DLN cell activation of BMM was induced by a combination of CD4+ T cells and B cells, 
which is the first time to show a direct role for B cells in macrophage activation to control 
Leishmania infection. The killing of the intracellular L. amazonensis infection in this system 
was dependent on secreted factors including antibody. Once again similar to the previous 
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study this killing of intracellular L. amazonensis amastigotes by the BMM was dependent on 
superoxide while L. major killing was not. 
The antibody dependent killing of L. amazonensis was not reproducible using 
immune serum alone or with either IFN-y or CD4+ T cells from L. major cells infected mice. 
These results indicate that other factors are needed in addition to antibody to induce 
intracellular parasite killing. The factors needed may be required to induce effective 
macrophages antibody receptor (FcR) expression and promote macrophage activation and 
superoxide secretion. Leishmania infection of macrophages influenced FcR expression of 
these receptors by downregulating the mRNA expression of the activator Fey I receptor 
(CD64) and upregulating the mRNA expression of the inhibitory receptor FcyRII (CD32). It 
seems that beside antibody production, DLN cells from L. major secrete factor(s) to 
downregulate CD32 mRNA expression and at the same time induces the mRNA expression 
of CD64 in a balance to allow macrophage activation by antibodies and induction of 
superoxide to kill intracellular L. amazonensis amastigotes. 
These studies emphasis the necessity to have superoxide as a key factor, in the 
presence of nitric oxide, to kill L. amazonensis and it is seems that one of the major 
resistance strategies for L. amazonensis survival inside the macrophages is to prevent 
superoxide production. 
As summary for this study, we drew a model for our understanding of the mechanism 
by which DLN from L. major infected mice induce BMM to kill intracellular L. amazonensis 
amastigotes (Diagram 1). We think that the L. major antigen is needed to activate L. major 
antigen specific CD4+ T cells and B cells to produce antibodies and, as yet unknown, specific 
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factors for upregulation CD64 expression and downregulation of CD32. The L. major 
specific antibody (IgG2a) binds CD64 and in the presence of L. major antigen that binds to 
the receptor bound antibodies causes the CD64 to aggregate and signals through their IT AM 
motifs to activate signaling cascades including PKC and PLC that result in macrophage 
superoxide production. Superoxide in the presence of nitric oxide subsequently produce 
peroxynirite, which is one of the most known potent endogenous cytotoxic factors, which 
would ultimately kill intracellular L. amazonensis. 
Superoxide 
Parasite 
Killing 
Nitric oxide 
Diagram 1. Proposed model for the mechanism of DLN cells from L. major infected mice 
induce BMM to kill intracellular L. amazonensis amastigotes. 
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Figure Al. IL-10 is not responsible for the delayed killing of L. amazonensis in comparison 
to L. major. BMM from IL-10 deficient and C57BL/6 mice were infected and activated with 
LPS and IFN-r as described in Fig. 1. The percent of the macrophages that were infected for 
each treatment group was determined at the days indicated and the % of the non-activated 
control was calculated as described in Fig 1. The data shown are the mean ± standard error 
from 2 independent experiments with 3 replicates in each. (*= p<0.05 ANOVA, Scheffe's 
test for paired comparison) 
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Figure A2. NADPH-oxidase pathway does not contribute to the kinetics of amastigote 
killing for either Leishmania major or L. amazonensis infected macrophages. BMM from 
C57BL/6J and gp91phox deficient mice were infected and activated with LPS and IFN-y as 
described in Fig. 1. The percent of macrophages that were infected for each treatment group 
was determined at the days indicated, and the % of the non-activated controls was calculated 
as described in Fig. 1. The data shown are the mean ± standard error from 2 independent 
experiments with 2 replicates in each experiment. 
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Figure A3. Both Total IgG and IgG2a are lower in cultures with LN cells 
from L. amazonensis infected mice. LN cells and macrophage infection was 
done as described in chapter 3. The macrophages were infected with L. 
amazonensis LN cells and LN cells from either L. major or L. amazonensis 
infected mice and incubated with antigen for 5 days. The levels of Total IgG 
(a) and IgG2a (b) were determined by immunobloting the supernatant of the 
cultures with goat anti-mouse IgG HRP or goat anti-mouse IgG2a HRP, 
respectively. These results are the average of the densotometry of at least 3 
experiments with standard error bar. 
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Figure A4. Flow staining for CD19 in; a. total LN cells, b. CD19+ cells 
depleted population, and c. negatively selected B cells. The stain used was PE 
labeled anti-mouse antibody. 
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Figure AS. Flow staining for CDS in; a. total LN cells, b. CD8+ cells depleted 
population,and c. negatively selected CD8+ cells. The stain used was FITC labeled 
anti-mouse antibody. 
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Figure A6. Flow staining for CD4 in a. total LN cells, b. CD4+ T 
cells depleted population, and c. negatively selected CD4+ T cells. 
The stain used was FITC labeled anti-mouse antibody. 
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